DAVID GRAHAM

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address2002 HOLCOMBE
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular Virology & Microbiology
    DivisionMolecular Virology & Microbiology


    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    R01DK039919     (GRAHAM, DAVID Y)Sep 23, 1987 - Aug 31, 1992
    NIH/NIDDK
    CAMPYLOBACTER PYLORIDIS IN GASTRODUODENAL DISEASE
    Role: Principal Investigator

    R01DK053659     (GRAHAM, DAVID Y)Sep 30, 1997 - Sep 29, 2001
    NIH/NIDDK
    IDENT OF H PYLORI VIRUL FACTORS IN ETHNIC POPULATIONS
    Role: Principal Investigator

    R01DK063092     (GRAHAM, DAVID Y)May 1, 2002 - Apr 30, 2007
    NIH/NIDDK
    The Role of Mycobacteria in Crohn's Disease
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Howden CW, Graham DY. Recent Developments Pertaining to H. pylori Infection. Am J Gastroenterol. 2021 01 01; 116(1):1-3. PMID: 33378314.
      Citations:    Fields:    Translation:HumansCells
    2. Tan MC, Graham DY. Screening for Gastric Cancer: Focus on the Ants Instead of the Ant Hill. Clin Gastroenterol Hepatol. 2020 Nov 26. PMID: 33248078.
      Citations:    Fields:    
    3. Ertan A, Yurdaydin C, Graham DY. Professor Ali Ozden, MD (1942-2020). Gastroenterology. 2020 Nov 19. PMID: 33556343.
      Citations:    Fields:    
    4. Graham DY, Megraud F. Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapy. Helicobacter. 2021 Feb; 26(1):e12773. PMID: 33207391.
      Citations:    Fields:    
    5. Järbrink-Sehgal ME, Sparkman J, Damron A, Walker MM, Green LK, Rosen DG, Graham DY, El-Serag HE. Functional Dyspepsia and Duodenal Eosinophil Count and Degranulation: A Multiethnic US Veteran Cohort Study. Dig Dis Sci. 2020 Nov 13. PMID: 33185786.
      Citations:    Fields:    
    6. Kalfus IN, Graham DY, Riff DS, Panas RM. Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of Helicobacter pylori: Randomized ERADICATE Hp Trial. Antibiotics (Basel). 2020 Oct 09; 9(10). PMID: 33050205.
      Citations:    
    7. Graham DY. Transitioning of Helicobacter pylori Therapy from Trial and Error to Antimicrobial Stewardship. Antibiotics (Basel). 2020 Oct 03; 9(10). PMID: 33023041.
      Citations:    
    8. Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC, Yeoh KG, Hsu PI, Goh KL, Mahachai V, Gotoda T, Chang WL, Chen MJ, Chiang TH, Chen CC, Wu CY, Leow AH, Wu JY, Wu DC, Hong TC, Lu H, Yamaoka Y, Megraud F, Chan FKL, Sung JJ, Lin JT, Graham DY, Wu MS, El-Omar EM. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020 Dec; 69(12):2093-2112. PMID: 33004546.
      Citations: 2     Fields:    
    9. Graham DY, El-Serag HB. European Registry on Helicobacter pylori management shows that gastroenterology has largely failed in its efforts to guide practitioners. Gut. 2021 Jan; 70(1):1-2. PMID: 32958543.
      Citations: 1     Fields:    
    10. Gurwara S, Dai A, Ajami NJ, Graham DY, White DL, Chen L, Jang A, Chen E, El-Serag HB, Petrosino JF, Jiao L. Alcohol use alters the colonic mucosa-associated gut microbiota in humans. Nutr Res. 2020 11; 83:119-128. PMID: 33096423.
      Citations:    Fields:    
    11. Graham DY, Lu H, Shiotani A. Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance. J Gastroenterol Hepatol. 2020 Sep 12. PMID: 32918832.
      Citations:    Fields:    
    12. Chiang TH, Chang WJ, Chen SL, Yen AM, Fann JC, Chiu SY, Chen YR, Chuang SL, Shieh CF, Liu CY, Chiu HM, Chiang H, Shun CT, Lin MW, Wu MS, Lin JT, Chan CC, Graham DY, Chen HH, Lee YC. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. 2021 Feb; 70(2):243-250. PMID: 32792335.
      Citations:    Fields:    
    13. Chiang TH, Maeda M, Yamada H, Chan CC, Chen SL, Chiu SY, Chen YN, Chou YH, Shieh CF, Liu CY, Chiu HM, Chiang H, Shun CT, Lin MW, Wu MS, Lin JT, Chen HH, Ushijima T, Graham DY, Lee YC. Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands. J Gastroenterol Hepatol. 2020 Jul 15. PMID: 32671873.
      Citations: 1     Fields:    
    14. Tansel A, Graham DY. Stress Ulcer Prophylaxis for ICU Patients. JAMA. 2020 07 07; 324(1):101. PMID: 32633798.
      Citations:    Fields:    Translation:Humans
    15. Graham DY, Canaan Y, Maher J, Wiener G, Hulten KG, Kalfus IN. Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial. Ann Intern Med. 2020 06 16; 172(12):795-802. PMID: 32365359.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    16. Gao CP, Zhang D, Zhang T, Wang JX, Han SX, Graham DY, Lu H. PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis. Helicobacter. 2020 Aug; 25(4):e12692. PMID: 32314468.
      Citations: 1     Fields:    
    17. Engstrand L, Graham DY. Microbiome and Gastric Cancer. Dig Dis Sci. 2020 03; 65(3):865-873. PMID: 32040665.
      Citations: 2     Fields:    Translation:HumansCells
    18. Horiuchi A, Graham DY. High-flow nasal cannula oxygen therapy obscures severe respiration depression, providing an illusion of safety. Gastrointest Endosc. 2020 03; 91(3):720-721. PMID: 32087904.
      Citations:    Fields:    Translation:Humans
    19. Luo L, Ji Y, Yu L, Huang Y, Liang X, Graham DY, Lu H. 14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment. Dig Dis Sci. 2020 12; 65(12):3639-3646. PMID: 32020360.
      Citations: 1     Fields:    
    20. Graham DY, Tan MC. No Barrett's-No Cancer: A Proposed New Paradigm for Prevention of Esophageal Adenocarcinoma. J Clin Gastroenterol. 2020 02; 54(2):136-143. PMID: 31851107.
      Citations: 1     Fields:    
    21. Murakami K, Tenge VR, Karandikar UC, Lin SC, Ramani S, Ettayebi K, Crawford SE, Zeng XL, Neill FH, Ayyar BV, Katayama K, Graham DY, Bieberich E, Atmar RL, Estes MK. Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 01 21; 117(3):1700-1710. PMID: 31896578.
      Citations: 11     Fields:    Translation:HumansCells
    22. Graham DY, Rugge M, Genta RM. Diagnosis: gastric intestinal metaplasia - what to do next? Curr Opin Gastroenterol. 2019 11; 35(6):535-543. PMID: 31415250.
      Citations: 1     Fields:    Translation:Humans
    23. Dore MP, Bibbò S, Loria M, Salis R, Manca A, Pes GM, Graham DY. Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera® or Lactobacillus reuteri for treatment naïve or for retreatment of Helicobacter pylori. Two randomized pilot studies. Helicobacter. 2019 Dec; 24(6):e12659. PMID: 31502382.
      Citations:    Fields:    Translation:HumansCells
    24. Yu L, Luo L, Long X, Liang X, Ji Y, Chen Q, Song Y, Li X, Graham DY, Lu H. Susceptibility-guided therapy for Helicobacter pylori infection treatment failures. Therap Adv Gastroenterol. 2019; 12:1756284819874922. PMID: 31523279.
      Citations:    
    25. Tan MC, Graham DY. Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020. Gastrointest Endosc. 2019 09; 90(3):457-460. PMID: 31439130.
      Citations:    Fields:    Translation:HumansCells
    26. Liu Y, Ajami NJ, El-Serag HB, Hair C, Graham DY, White DL, Chen L, Wang Z, Plew S, Kramer J, Cole R, Hernaez R, Hou J, Husain N, Jarbrink-Sehgal ME, Kanwal F, Ketwaroo G, Natarajan Y, Shah R, Velez M, Mallepally N, Petrosino JF, Jiao L. Dietary quality and the colonic mucosa-associated gut microbiome in humans. Am J Clin Nutr. 2019 09 01; 110(3):701-712. PMID: 31291462.
      Citations: 10     Fields:    Translation:HumansCells
    27. Graham DY, Dang BN, El-Serag HB. Helicobacter pylori Infection. N Engl J Med. 2019 08 08; 381(6):587-588. PMID: 31390511.
      Citations:    Fields:    Translation:HumansCells
    28. Lu H, Graham DY. Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment-authors' reply. Aliment Pharmacol Ther. 2019 08; 50(3):332. PMID: 31313359.
      Citations:    Fields:    Translation:HumansCells
    29. Estes MK, Ettayebi K, Tenge VR, Murakami K, Karandikar U, Lin SC, Ayyar BV, Cortes-Penfield NW, Haga K, Neill FH, Opekun AR, Broughman JR, Zeng XL, Blutt SE, Crawford SE, Ramani S, Graham DY, Atmar RL. Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges. Viruses. 2019 07 11; 11(7). PMID: 31336765.
      Citations: 8     Fields:    Translation:HumansCells
    30. Graham DY, Jewell NP, Chan FKL. Rofecoxib and Clinically Significant Gastrointestinal Events: Response. Am J Med Sci. 2019 09; 358(3):e9-e10. PMID: 31301755.
      Citations: 1     Fields:    Translation:Humans
    31. Rugge M, Sacchi D, Graham DY, Genta RM. Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging. Gut. 2020 06; 69(6):1151-1152. PMID: 31186295.
      Citations: 1     Fields:    
    32. Yu L, Luo L, Long X, Liang X, Ji Y, Graham DY, Lu H. High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial. Helicobacter. 2019 Aug; 24(4):e12596. PMID: 31111580.
      Citations: 6     Fields:    Translation:HumansCells
    33. Chen Q, Long X, Ji Y, Liang X, Li D, Gao H, Xu B, Liu M, Chen Y, Sun Y, Zhao Y, Xu G, Song Y, Yu L, Zhang W, Liu W, Graham DY, Lu H. Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment. Aliment Pharmacol Ther. 2019 06; 49(11):1385-1394. PMID: 31020673.
      Citations: 8     Fields:    Translation:HumansCells
    34. Uotani T, Murakami K, Uchida T, Tanaka S, Nagashima H, Zeng XL, Akada J, Estes MK, Graham DY, Yamaoka Y. Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection. Helicobacter. 2019 Jun; 24(3):e12583. PMID: 30950121.
      Citations: 1     Fields:    Translation:HumansCells
    35. Dore MP, Bibbò S, Pes GM, Francavilla R, Graham DY. Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor. Can J Infect Dis Med Microbiol. 2019; 2019:3409820. PMID: 31065301.
      Citations:    
    36. Gurwara S, Ajami NJ, Jang A, Hessel FC, Chen L, Plew S, Wang Z, Graham DY, Hair C, White DL, Kramer J, Kourkoumpetis T, Hoffman K, Cole R, Hou J, Husain N, Jarbrink-Sehgal M, Hernaez R, Kanwal F, Ketwaroo G, Shah R, Velez M, Natarajan Y, El-Serag HB, Petrosino JF, Jiao L. Dietary Nutrients Involved in One-Carbon Metabolism and Colonic Mucosa-Associated Gut Microbiome in Individuals with an Endoscopically Normal Colon. Nutrients. 2019 Mar 13; 11(3). PMID: 30871224.
      Citations: 4     Fields:    Translation:HumansCells
    37. Tan MC, Tansel A, Graham DY. Pantoprazole in Patients in the ICU. N Engl J Med. 2019 03 07; 380(10):984. PMID: 30855751.
      Citations:    Fields:    Translation:Humans
    38. El-Serag HB, Graham DY. Reply. Clin Gastroenterol Hepatol. 2019 06; 17(7):1420. PMID: 30710706.
      Citations:    Fields:    Translation:HumansCells
    39. Ihekweazu FD, Fofanova TY, Queliza K, Nagy-Szakal D, Stewart CJ, Engevik MA, Hulten KG, Tatevian N, Graham DY, Versalovic J, Petrosino JF, Kellermayer R. Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model. Gut Microbes. 2019; 10(4):504-520. PMID: 30663928.
      Citations: 7     Fields:    Translation:AnimalsCells
    40. Graham DY. Optimal PPI Dosing for Improving GERD Symptoms: Is Timing Everything? Dig Dis Sci. 2019 01; 64(1):4-6. PMID: 30238199.
      Citations:    Fields:    Translation:Humans
    41. Matsumoto H, Shiotani A, Graham DY. Current and Future Treatment of Helicobacter pylori Infections. Adv Exp Med Biol. 2019; 1149:211-225. PMID: 31016626.
      Citations: 4     Fields:    Translation:HumansCells
    42. Ketwaroo GA, Graham DY. Rational Use of Pancreatic Enzymes for Pancreatic Insufficiency and Pancreatic Pain. Adv Exp Med Biol. 2019; 1148:323-343. PMID: 31482505.
      Citations:    Fields:    Translation:Humans
    43. El-Serag HB, Graham DY. Reply. Clin Gastroenterol Hepatol. 2018 12; 16(12):2004. PMID: 30454938.
      Citations:    Fields:    Translation:HumansCells
    44. El-Serag HB, Graham DY. Reply. Clin Gastroenterol Hepatol. 2018 12; 16(12):2005-2006. PMID: 30454939.
      Citations:    Fields:    Translation:HumansCells
    45. Graham DY, Lu H, Dore MP. Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI. Helicobacter. 2019 Feb; 24(1):e12554. PMID: 30440097.
      Citations: 6     Fields:    Translation:HumansCells
    46. Wu JY, Lee YC, Graham DY. The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal. Expert Rev Gastroenterol Hepatol. 2019 Jan; 13(1):17-24. PMID: 30791844.
      Citations: 2     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    47. Leow AH, Azmi AN, Loke MF, Vadivelu J, Graham DY, Goh KL. Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better? J Dig Dis. 2018 Nov; 19(11):674-677. PMID: 30307122.
      Citations: 1     Fields:    Translation:HumansCells
    48. Graham DY, Zou WY. Guilt by association: intestinal metaplasia does not progress to gastric cancer. Curr Opin Gastroenterol. 2018 11; 34(6):458-464. PMID: 30138135.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    49. Graham DY, Ketwaroo GA, Money ME, Opekun AR. Enzyme therapy for functional bowel disease-like post-prandial distress. J Dig Dis. 2018 Nov; 19(11):650-656. PMID: 30101562.
      Citations: 1     Fields:    Translation:Humans
    50. Graham DY, Dore MP, Lu H. Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies. Expert Rev Anti Infect Ther. 2018 09; 16(9):679-687. PMID: 30102559.
      Citations: 6     Fields:    Translation:HumansCells
    51. Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology. 2018 11; 155(5):1372-1382.e17. PMID: 29990487.
      Citations: 66     Fields:    Translation:HumansCells
    52. Malfertheiner P, Selgrad M, Wex T, Romi B, Borgogni E, Spensieri F, Zedda L, Ruggiero P, Pancotto L, Censini S, Palla E, Kanesa-Thasan N, Scharschmidt B, Rappuoli R, Graham DY, Schiavetti F, Del Giudice G. Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study. Lancet Gastroenterol Hepatol. 2018 10; 3(10):698-707. PMID: 30042064.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    53. Yeomans ND, Graham DY, Wang Q, Wolski K, Borer J, Husni EM, Libby P, Lincoff MA, Lüscher T, Wisniewski LM, Bao W, Walker C, Nissen SE. Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial. Am J Gastroenterol. 2018 07; 113(7):1053-1054. PMID: 29535414.
      Citations:    Fields:    Translation:Humans
    54. Wang Z, Graham DY, Khan A, Balakrishnan M, Abrams HR, El-Serag HB, Thrift AP. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis. Int J Epidemiol. 2018 Jun 01; 47(3):966-975. PMID: 29672681.
      Citations: 6     Fields:    
    55. Yeomans ND, Graham DY. Editorial: gastrointestinal safety of COX-2 selective and nonselective NSAIDs-the impact of the PRECISION trial. Authors' reply. Aliment Pharmacol Ther. 2018 06; 47(11):1546-1547. PMID: 29878426.
      Citations:    
    56. Reed GW, Abdallah MS, Shao M, Wolski K, Wisniewski L, Yeomans N, Lüscher TF, Borer JS, Graham DY, Husni ME, Solomon DH, Libby P, Menon V, Lincoff AM, Nissen SE. Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen. J Am Coll Cardiol. 2018 04 24; 71(16):1741-1751. PMID: 29673465.
      Citations: 3     Fields:    Translation:Humans
    57. Yeomans ND, Graham DY, Husni ME, Solomon DH, Stevens T, Vargo J, Wang Q, Wisniewski LM, Wolski KE, Borer JS, Libby P, Lincoff AM, Lüscher TF, Bao W, Walker C, Nissen SE. Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial. Aliment Pharmacol Ther. 2018 06; 47(11):1453-1463. PMID: 29667211.
      Citations:    
    58. Solomon DH, Husni ME, Wolski KE, Wisniewski LM, Borer JS, Graham DY, Libby P, Lincoff AM, Lüscher TF, Menon V, Yeomans ND, Wang Q, Bao W, Berger MF, Nissen SE. Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical Trial. Arthritis Rheumatol. 2018 04; 70(4):537-546. PMID: 29266879.
      Citations: 4     Fields:    Translation:Humans
    59. Hsu PI, Tsay FW, Graham DY, Tsai TJ, Tsai KW, Kao JY, Peng NJ, Kuo CH, Kao SS, Wang HM, Lin TF, Wu DC. Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2018 09; 16(9):1427-1433. PMID: 29609070.
      Citations: 3     Fields:    Translation:HumansCells
    60. Tan MC, Graham DY. Proton pump inhibitor therapy after Helicobacter pylori eradication may increase the risk of gastric cancer. BMJ Evid Based Med. 2018 06; 23(3):111-112. PMID: 29599181.
      Citations:    Fields:    Translation:HumansCells
    61. El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, Crowe SE, Elfant A, Haas T, Hapke RJ, Graham DY. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol. 2018 07; 16(7):992-1002.e6. PMID: 29559361.
      Citations: 18     Fields:    Translation:HumansCells
    62. Balakrishnan M, George R, Sharma A, Graham DY, Malaty HM. An Investigation into the Recent Increase in Gastric Cancer in the USA. Dig Dis Sci. 2018 06; 63(6):1613-1619. PMID: 29546646.
      Citations: 2     Fields:    Translation:Humans
    63. Leung WK, Wong IOL, Cheung KS, Yeung KF, Chan EW, Wong AYS, Chen L, Wong ICK, Graham DY. Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals. Gastroenterology. 2018 07; 155(1):67-75. PMID: 29550592.
      Citations: 13     Fields:    Translation:HumansCells
    64. Opekun AR, Gonzales SA, Al-Saadi MA, Graham DY. Brief report: Lactobacillus bulgaricus GLB44 (Proviotic™ ) plus esomeprazole for Helicobacter pylori eradication: A pilot study. Helicobacter. 2018 Apr; 23(2):e12476. PMID: 29504209.
      Citations:    Fields:    Translation:HumansCells
    65. Lee YC, Asaka M, Graham DY. Editorial: Helicobacter pylori and gastric cancer in Alaskan Natives: Time to stop studying H. pylori and to eradicate it. Helicobacter. 2018 06; 23(3):e12478. PMID: 29498154.
      Citations:    Fields:    Translation:HumansCells
    66. Graham DY, Miftahussurur M. Helicobacter pylori urease for diagnosis of Helicobacter pylori infection: A mini review. J Adv Res. 2018 Sep; 13:51-57. PMID: 30094082.
      Citations:    
    67. Graham DY, Dore MP. Update on the Use of Vonoprazan: A Competitive Acid Blocker. Gastroenterology. 2018 Feb; 154(3):462-466. PMID: 29337157.
      Citations: 9     Fields:    Translation:HumansCells
    68. Rugge M, Meggio A, Pravadelli C, Barbareschi M, Fassan M, Gentilini M, Zorzi M, Pretis G, Graham DY, Genta RM. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut. 2019 01; 68(1):11-17. PMID: 29306868.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    69. Bhakta D, Graham DY, Chan J, El-Serag HB. Lessons From Using Culture-Guided Treatment After Referral for Multiple Treatment Failures for Helicobacter pylori Infection. Clin Gastroenterol Hepatol. 2018 09; 16(9):1531-1532. PMID: 29306045.
      Citations: 2     Fields:    Translation:HumansCells
    70. Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH. Editorial: recurrence of Helicobacter pylori infection-still the same after all these years… Authors' reply. Aliment Pharmacol Ther. 2018 01; 47(1):132-133. PMID: 29226407.
      Citations:    
    71. Mahachai V, Vilaichone RK, Pittayanon R, Rojborwonwitaya J, Leelakusolvong S, Maneerattanaporn M, Chotivitayatarakorn P, Treeprasertsuk S, Kositchaiwat C, Pisespongsa P, Mairiang P, Rani A, Leow A, Mya SM, Lee YC, Vannarath S, Rasachak B, Chakravuth O, Aung MM, Ang TL, Sollano JD, Trong Quach D, Sansak I, Wiwattanachang O, Harnsomburana P, Syam AF, Yamaoka Y, Fock KM, Goh KL, Sugano K, Graham D. Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018 Jan; 33(1):37-56. PMID: 28762251.
      Citations: 15     Fields:    Translation:HumansCells
    72. Graham DY. Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis. Aliment Pharmacol Ther. 2017 12; 46(11-12):1117-1118. PMID: 29105138.
      Citations:    
    73. Ayub K, Ketwaroo G, Abudayyeh S, Ibrahim A, Cole RA, Brumfield-Brown R, Qureshi WA, Rabeneck L, Graham DY. Mechanical colon cleansing for screening colonoscopy: A randomized controlled trial. J Dig Dis. 2017 Dec; 18(12):691-697. PMID: 29160622.
      Citations:    Fields:    Translation:Humans
    74. Ruschitzka F, Borer JS, Krum H, Flammer AJ, Yeomans ND, Libby P, Lüscher TF, Solomon DH, Husni ME, Graham DY, Davey DA, Wisniewski LM, Menon V, Fayyad R, Beckerman B, Iorga D, Lincoff AM, Nissen SE. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. Eur Heart J. 2017 Nov 21; 38(44):3282-3292. PMID: 29020251.
      Citations: 12     Fields:    Translation:Humans
    75. Nell S, Estibariz I, Krebes J, Bunk B, Graham DY, Overmann J, Song Y, Spröer C, Yang I, Wex T, Korlach J, Malfertheiner P, Suerbaum S. Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection. Gastroenterology. 2018 02; 154(3):612-623.e7. PMID: 29066327.
      Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
    76. Graham DY, Tansel A. Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency. Clin Gastroenterol Hepatol. 2018 06; 16(6):800-808.e7. PMID: 28964908.
      Citations: 9     Fields:    Translation:Humans
    77. Kuenstner JT, Naser S, Chamberlin W, Borody T, Graham DY, McNees A, Hermon-Taylor J, Hermon-Taylor A, Dow CT, Thayer W, Biesecker J, Collins MT, Sechi LA, Singh SV, Zhang P, Shafran I, Weg S, Telega G, Rothstein R, Oken H, Schimpff S, Bach H, Bull T, Grant I, Ellingson J, Dahmen H, Lipton J, Gupta S, Chaubey K, Singh M, Agarwal P, Kumar A, Misri J, Sohal J, Dhama K, Hemati Z, Davis W, Hier M, Aitken J, Pierce E, Parrish N, Goldberg N, Kali M, Bendre S, Agrawal G, Baldassano R, Linn P, Sweeney RW, Fecteau M, Hofstaedter C, Potula R, Timofeeva O, Geier S, John K, Zayanni N, Malaty HM, Kahlenborn C, Kravitz A, Bulfon A, Daskalopoulos G, Mitchell H, Neilan B, Timms V, Cossu D, Mameli G, Angermeier P, Jelic T, Goethe R, Juste RA, Kuenstner L. The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017. Front Public Health. 2017; 5:208. PMID: 29021977.
      Citations:    
    78. Graham DY. Illusions regarding Helicobacter pylori clinical trials and treatment guidelines. Gut. 2017 12; 66(12):2043-2046. PMID: 28935677.
      Citations: 5     Fields:    Translation:HumansCells
    79. Thorell K, Bengtsson-Palme J, Liu OH, Palacios Gonzales RV, Nookaew I, Rabeneck L, Paszat L, Graham DY, Nielsen J, Lundin SB, Sjöling Å. In Vivo Analysis of the Viable Microbiota and Helicobacter pylori Transcriptome in Gastric Infection and Early Stages of Carcinogenesis. Infect Immun. 2017 10; 85(10). PMID: 28694295.
      Citations: 7     Fields:    Translation:HumansCells
    80. Tanaka S, Nagashima H, Cruz M, Uchida T, Uotani T, Jiménez Abreu JA, Mahachai V, Vilaichone RK, Ratanachu-Ek T, Tshering L, Graham DY, Yamaoka Y. Interleukin-17C in Human Helicobacter pylori Gastritis. Infect Immun. 2017 10; 85(10). PMID: 28739826.
      Citations: 1     Fields:    Translation:HumansCells
    81. Hu Y, Wan JH, Li XY, Zhu Y, Graham DY, Lu NH. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther. 2017 11; 46(9):773-779. PMID: 28892184.
      Citations:    
    82. Graham DY, Lu H, Shiotani A. Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now? Saudi J Gastroenterol. 2017 Sep-Oct; 23(5):265-267. PMID: 28937019.
      Citations: 1     Fields:    Translation:HumansCells
    83. Balakrishnan M, George R, Sharma A, Graham DY. Changing Trends in Stomach Cancer Throughout the World. Curr Gastroenterol Rep. 2017 Aug; 19(8):36. PMID: 28730504.
      Citations: 43     Fields:    Translation:HumansCells
    84. Miftahussurur M, Nusi IA, Graham DY, Yamaoka Y. Helicobacter, Hygiene, Atopy, and Asthma. Front Microbiol. 2017; 8:1034. PMID: 28642748.
      Citations:    
    85. Mohammadi M, Attaran B, Malekzadeh R, Graham DY. Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran. Dig Dis Sci. 2017 08; 62(8):1890-1896. PMID: 28577244.
      Citations: 8     Fields:    Translation:HumansCells
    86. Dang BN, Graham DY. It is time to rethink H. pylori therapy. J Gastrointestin Liver Dis. 2017 06; 26(2):115-117. PMID: 28617879.
      Citations:    Fields:    Translation:HumansCells
    87. Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY. Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017 Dec; 15(12):1833-1843. PMID: 28532700.
      Citations: 33     Fields:    Translation:Humans
    88. Dang BN, Graham DY. Helicobacter pylori infection and antibiotic resistance: a WHO high priority? Nat Rev Gastroenterol Hepatol. 2017 07; 14(7):383-384. PMID: 28465548.
      Citations: 13     Fields:    Translation:HumansCells
    89. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, Chan FKL, Sung JJY, Kaplan GG, Ng SC. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017 08; 153(2):420-429. PMID: 28456631.
      Citations: 207     Fields:    Translation:HumansCells
    90. Royse KE, Chen L, Berger DH, Ittmann MM, El-Serag HB, Balentine CJ, Graham DY, Richardson PA, Rumbaut RE, Shen X, White DL, Jiao L. Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma. Int J Mol Epidemiol Genet. 2017; 8(2):8-18. PMID: 28533893.
      Citations:    
    91. Tansel A, Graham DY. Reply. Clin Gastroenterol Hepatol. 2017 09; 15(9):1480-1481. PMID: 28419858.
      Citations:    Fields:    Translation:Humans
    92. Shiotani A, Lu H, Dore MP, Graham DY. Treating Helicobacter pylori effectively while minimizing misuse of antibiotics. Cleve Clin J Med. 2017 Apr; 84(4):310-318. PMID: 28388387.
      Citations: 7     Fields:    Translation:HumansCells
    93. Miftahussurur M, Yamaoka Y, Graham DY. Helicobacter pylori as an oncogenic pathogen, revisited. Expert Rev Mol Med. 2017 03 21; 19:e4. PMID: 28322182.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    94. Zayyani NR, Malaty HM, Graham DY. Increasing Incidence of Crohn's Disease with Familial Clustering in the Kingdom of Bahrain: A 25-Year Population-based Study. Inflamm Bowel Dis. 2017 02; 23(2):304-309. PMID: 28092308.
      Citations: 3     Fields:    Translation:Humans
    95. Tanaka S, Nagashima H, Uotani T, Graham DY, Yamaoka Y. Autophagy-related genes in Helicobacter pylori infection. Helicobacter. 2017 Jun; 22(3). PMID: 28111844.
      Citations: 4     Fields:    Translation:HumansCells
    96. Shiota S, Thrift AP, Green L, Shah R, Verstovsek G, Rugge M, Graham DY, El-Serag HB. Clinical Manifestations of Helicobacter pylori-Negative Gastritis. Clin Gastroenterol Hepatol. 2017 Jul; 15(7):1037-1046.e3. PMID: 28110098.
      Citations: 8     Fields:    Translation:Humans
    97. Graham DY, Fagoonee S, Pellicano R. Increasing role for modified bismuth-containing quadruple therapies for Helicobacter pylori eradication. Minerva Gastroenterol Dietol. 2017 06; 63(2):77-79. PMID: 28079346.
      Citations: 5     Fields:    Translation:HumansCells
    98. Tansel A, Graham DY. New Insight Into an Effective Treatment of Marginal Ulceration After Roux-en-Y Gastric Bypass. Clin Gastroenterol Hepatol. 2017 04; 15(4):501-503. PMID: 28062217.
      Citations: 1     Fields:    Translation:Humans
    99. Yamaoka Y, Graham DY. Empiric H. pylori therapy-10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best. Transl Cancer Res. 2016 Dec; 5(Suppl 7):S1476-S1478. PMID: 28819587.
      Citations:    
    100. Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med. 2016 12 29; 375(26):2519-29. PMID: 27959716.
      Citations: 102     Fields:    Translation:Humans
    101. Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017 01; 66(1):6-30. PMID: 27707777.
      Citations:    
    102. Graham DY. Upper Gastrointestinal Bleeding Due to a Peptic Ulcer. N Engl J Med. 2016 09 22; 375(12):1197-8. PMID: 27653583.
      Citations:    Fields:    Translation:Humans
    103. Matsumoto H, Shiotani A, Katsumata R, Fujita M, Nakato R, Murao T, Ishii M, Kamada T, Haruma K, Graham DY. Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. Dig Dis Sci. 2016 11; 61(11):3215-3220. PMID: 27659671.
      Citations: 16     Fields:    Translation:HumansCells
    104. Miftahussurur M, Yamaoka Y, Graham DY. Helicobacter pylori vacuolating cytotoxin and gastric cancer risk: reconsidered. Transl Cancer Res. 2016 Sep; 5(Suppl 3):S557-S560. PMID: 28649559.
      Citations:    
    105. Lee YC, Liao WC, Wu MS, Graham DY. Reply. Gastroenterology. 2016 10; 151(4):774-5. PMID: 27590691.
      Citations:    Fields:    
    106. Ettayebi K, Crawford SE, Murakami K, Broughman JR, Karandikar U, Tenge VR, Neill FH, Blutt SE, Zeng XL, Qu L, Kou B, Opekun AR, Burrin D, Graham DY, Ramani S, Atmar RL, Estes MK. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016 09 23; 353(6306):1387-1393. PMID: 27562956.
      Citations: 290     Fields:    Translation:HumansCells
    107. Hobbs PM, Johnson WG, Graham DY. Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes. World J Gastrointest Pharmacol Ther. 2016 Aug 06; 7(3):370-86. PMID: 27602238.
      Citations:    
    108. Trespalacios-Rangél AA, Otero W, Arévalo-Galvis A, Poutou-Piñales RA, Rimbara E, Graham DY. Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014). PLoS One. 2016; 11(7):e0160007. PMID: 27454429.
      Citations: 4     Fields:    Translation:HumansCells
    109. Dore MP, Pes GM, Bassotti G, Farina MA, Marras G, Graham DY. Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia. Scand J Gastroenterol. 2016 Nov; 51(11):1281-7. PMID: 27381266.
      Citations: 6     Fields:    Translation:HumansCells
    110. Kwack W, Lim Y, Lim C, Graham DY. High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea. Gastroenterol Res Pract. 2016; 2016:1648047. PMID: 27413365.
      Citations:    
    111. Graham DY, Laine L. The Toronto Helicobacter pylori Consensus in Context. Gastroenterology. 2016 07; 151(1):9-12. PMID: 27215659.
      Citations: 2     Fields:    Translation:HumansCells
    112. Graham DY, Dore MP. Helicobacter pylori therapy: a paradigm shift. Expert Rev Anti Infect Ther. 2016 06; 14(6):577-85. PMID: 27077447.
      Citations: 18     Fields:    Translation:HumansCells
    113. Horiuchi A, Makino T, Kajiyama M, Tanaka N, Sano K, Graham DY. Comparison between endoscopic mucosal resection and hot snare resection of large nonpedunculated colorectal polyps: a randomized trial. Endoscopy. 2016 Jul; 48(7):646-51. PMID: 27100717.
      Citations:    
    114. Graham DY. Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues. Gut. 2017 02; 66(2):384-386. PMID: 27056876.
      Citations: 7     Fields:    Translation:HumansCells
    115. Thorell K, Hosseini S, Palacios Gonzáles RV, Chaotham C, Graham DY, Paszat L, Rabeneck L, Lundin SB, Nookaew I, Sjöling Å. Identification of a Latin American-specific BabA adhesin variant through whole genome sequencing of Helicobacter pylori patient isolates from Nicaragua. BMC Evol Biol. 2016 Feb 29; 16:53. PMID: 26928576.
      Citations: 10     Fields:    Translation:HumansCells
    116. Rugge M, Genta RM, Graham DY, Di Mario F, Vaz Coelho LG, Kim N, Malfertheiner P, Sugano K, Tsukanov V, Correa P. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut. 2016 May; 65(5):721-5. PMID: 26927528.
      Citations: 7     Fields:    Translation:Humans
    117. Dore MP, Lu H, Graham DY. Role of bismuth in improving Helicobacter pylori eradication with triple therapy. Gut. 2016 May; 65(5):870-8. PMID: 26848181.
      Citations: 33     Fields:    Translation:HumansCells
    118. Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016 05; 150(5):1113-1124.e5. PMID: 26836587.
      Citations: 100     Fields:    Translation:HumansCells
    119. Hashmi A, Keswani NR, Kim S, Graham DY. Hepatic Dysfunction in Patients Receiving Intravenous Amiodarone. South Med J. 2016 Feb; 109(2):83-6. PMID: 26840961.
      Citations: 1     Fields:    Translation:Humans
    120. Uotani T, Sugimoto M, Ichikawa H, Tanaka S, Nagashima H, Uchida T, Graham DY, Yamaoka Y. Prostate stem cell antigen gene TT genotype and development of intestinal metaplasia in Helicobacter pylori infection. J Dig Dis. 2016 Jan; 17(1):20-7. PMID: 26706772.
      Citations: 1     Fields:    Translation:HumansCells
    121. Lee YC, Chiang TH, Liou JM, Chen HH, Wu MS, Graham DY. Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical Considerations. Gut Liver. 2016 Jan; 10(1):12-26. PMID: 26696028.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    122. Hsu PI, Lin PC, Graham DY. Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis. World J Gastroenterol. 2015 Dec 07; 21(45):12954-62. PMID: 26668516.
      Citations: 10     Fields:    Translation:HumansCells
    123. Graham DY. Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype. Helicobacter. 2016 Apr; 21(2):85-90. PMID: 26612515.
      Citations: 12     Fields:    Translation:HumansCells
    124. Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Autoimmune gastritis: Pathologist's viewpoint. World J Gastroenterol. 2015 Nov 14; 21(42):12179-89. PMID: 26576102.
      Citations: 17     Fields:    Translation:HumansCells
    125. McNees AL, Markesich D, Zayyani NR, Graham DY. Mycobacterium paratuberculosis as a cause of Crohn's disease. Expert Rev Gastroenterol Hepatol. 2015; 9(12):1523-34. PMID: 26474349.
      Citations: 25     Fields:    Translation:HumansAnimalsCells
    126. Saxena K, Blutt SE, Ettayebi K, Zeng XL, Broughman JR, Crawford SE, Karandikar UC, Sastri NP, Conner ME, Opekun AR, Graham DY, Qureshi W, Sherman V, Foulke-Abel J, In J, Kovbasnjuk O, Zachos NC, Donowitz M, Estes MK. Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology. J Virol. 2016 01 01; 90(1):43-56. PMID: 26446608.
      Citations: 103     Fields:    Translation:HumansCells
    127. Zhang W, Chen Q, Liang X, Liu W, Xiao S, Graham DY, Lu H. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy. Gut. 2015 Nov; 64(11):1715-20. PMID: 26338726.
      Citations: 20     Fields:    Translation:HumansCells
    128. Graham DY, Gisbert JP. Letter: clarithromycin dose for H. pylori therapy remains unresolved. Aliment Pharmacol Ther. 2015 Sep; 42(5):631-2. PMID: 26238583.
      Citations:    Fields:    Translation:Humans
    129. Hillard JR, Graham DY. It is not all black and white: Future incidence of stomach cancer will be substantially higher than projected due to the effects of immigration and increasing Hispanic and Asian populations in the United States. Cancer. 2015 Dec 01; 121(23):4266-7. PMID: 26280930.
      Citations:    
    130. Shiotani A, Graham DY. Helicobacter pylori: New Thoughts and Practices. Gastroenterol Clin North Am. 2015 Sep; 44(3):xv-xvi. PMID: 26314679.
      Citations: 1     Fields:    Translation:HumansCells
    131. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015 Sep; 64(9):1353-67. PMID: 26187502.
      Citations: 177     Fields:    Translation:HumansCells
    132. Dore MP, Tufano MO, Pes GM, Cuccu M, Farina V, Manca A, Graham DY. Tissue resonance interaction accurately detects colon lesions: A double-blind pilot study. World J Gastroenterol. 2015 Jul 07; 21(25):7851-9. PMID: 26167085.
      Citations: 3     Fields:    Translation:Humans
    133. Graham DY. Editorial--Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants. Helicobacter. 2015 Oct; 20(5):321-5. PMID: 26123529.
      Citations: 9     Fields:    Translation:Cells
    134. Graham DY, Lee SY. How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly. Gastroenterol Clin North Am. 2015 Sep; 44(3):537-63. PMID: 26314667.
      Citations: 19     Fields:    Translation:HumansCells
    135. Atmar RL, Bernstein DI, Lyon GM, Treanor JJ, Al-Ibrahim MS, Graham DY, Vinjé J, Jiang X, Gregoricus N, Frenck RW, Moe CL, Chen WH, Ferreira J, Barrett J, Opekun AR, Estes MK, Borkowski A, Baehner F, Goodwin R, Edmonds A, Mendelman PM. Serological Correlates of Protection against a GII.4 Norovirus. Clin Vaccine Immunol. 2015 Aug; 22(8):923-9. PMID: 26041041.
      Citations: 32     Fields:    Translation:HumansCellsCTClinical Trials
    136. Graham DY, Lu H. Letter: bismuth, levofloxacin, amoxicillin, PPI quadruple therapy is not an effective first or second line regimen in the presence of levofloxacin resistance. Aliment Pharmacol Ther. 2015 Jun; 41(11):1220-1. PMID: 25939469.
      Citations:    Fields:    Translation:Humans
    137. Nagashima H, Iwatani S, Cruz M, Jiménez Abreu JA, Uchida T, Mahachai V, Vilaichone RK, Graham DY, Yamaoka Y. Toll-like Receptor 10 in Helicobacter pylori Infection. J Infect Dis. 2015 Nov 15; 212(10):1666-76. PMID: 25977263.
      Citations: 16     Fields:    Translation:HumansCells
    138. Horiuchi A, Hosoi K, Kajiyama M, Tanaka N, Sano K, Graham DY. Prospective, randomized comparison of 2 methods of cold snare polypectomy for small colorectal polyps. Gastrointest Endosc. 2015 Oct; 82(4):686-92. PMID: 25922251.
      Citations: 20     Fields:    Translation:Humans
    139. Molina-Infante J, Graham DY, Gisbert JP. Editorial: quadruple therapy for H. pylori eradication is better than triple therapy - authors' reply. Aliment Pharmacol Ther. 2015 Apr; 41(7):695-6. PMID: 25736143.
      Citations:    
    140. Dore MP, Marras G, Rocchi C, Soro S, Loria MF, Bassotti G, Graham DY, Malaty HM, Pes GM. Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic Sardinian patients. Intern Emerg Med. 2015 Oct; 10(7):787-94. PMID: 25739590.
      Citations: 8     Fields:    Translation:HumansCells
    141. Graham DY. Roadmap for elimination of gastric cancer in Korea. Korean J Intern Med. 2015 Mar; 30(2):133-9. PMID: 25750552.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    142. Nguyen T, Ramsey D, Graham D, Shaib Y, Shiota S, Velez M, Cole R, Anand B, Vela M, El-Serag HB. The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans. Helicobacter. 2015 Aug; 20(4):305-15. PMID: 25689684.
      Citations: 10     Fields:    Translation:HumansCells
    143. Shiota S, Reddy R, Alsarraj A, El-Serag HB, Graham DY. Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1616-24. PMID: 25681693.
      Citations: 33     Fields:    Translation:HumansCells
    144. Schaefer JS, Attumi T, Opekun AR, Abraham B, Hou J, Shelby H, Graham DY, Streckfus C, Klein JR. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis. BMC Immunol. 2015 Feb 10; 16:5. PMID: 25886994.
      Citations: 49     Fields:    Translation:HumansCells
    145. Graham DY. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015 Apr; 148(4):719-31.e3. PMID: 25655557.
      Citations: 96     Fields:    Translation:HumansCells
    146. Ramani S, Neill FH, Opekun AR, Gilger MA, Graham DY, Estes MK, Atmar RL. Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis. 2015 Aug 01; 212(3):397-405. PMID: 25635121.
      Citations: 37     Fields:    Translation:HumansCells
    147. Kamada T, Haruma K, Ito M, Inoue K, Manabe N, Matsumoto H, Kusunoki H, Hata J, Yoshihara M, Sumii K, Akiyama T, Tanaka S, Shiotani A, Graham DY. Time Trends in Helicobacter pylori Infection and Atrophic Gastritis Over 40 Years in Japan. Helicobacter. 2015 Jun; 20(3):192-8. PMID: 25581708.
      Citations: 22     Fields:    Translation:HumansCells
    148. Graham DY, Matsueda S, Shiotani A. Changing the natural history of metachronous gastric cancer after H. pylori eradication. Jpn J Helicobacter Res. 2015; 16(2):42-50. PMID: 28042524.
      Citations:    
    149. Uotani T, Graham DY. Diagnosis of Helicobacter pylori using the rapid urease test. Ann Transl Med. 2015 Jan; 3(1):9. PMID: 25705641.
      Citations:    
    150. Czakó R, Atmar RL, Opekun AR, Gilger MA, Graham DY, Estes MK. Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity. Clin Vaccine Immunol. 2015 Feb; 22(2):221-8. PMID: 25540269.
      Citations: 11     Fields:    Translation:HumansCells
    151. Trespalacios AA, Rimbara E, Otero W, Reddy R, Graham DY. Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA. Diagn Microbiol Infect Dis. 2015 Apr; 81(4):251-5. PMID: 25600075.
      Citations: 9     Fields:    Translation:HumansCells
    152. Nguyen TH, Thrift AP, Ramsey D, Green L, Shaib YH, Graham DY, El-Serag HB. Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80. PMID: 25420546.
      Citations: 10     Fields:    Translation:HumansCells
    153. Graham DY, Asaka M. RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst. 2014 Nov; 106(11). PMID: 25381392.
      Citations: 1     Fields:    Translation:HumansCells
    154. Nagashima H, Iwatani S, Cruz M, Jiménez Abreu JA, Tronilo L, Rodríguez E, Disla M, Terao H, Uchida T, Mahachai V, Vilaichone RK, Tshering L, Mitsui T, Shiota S, Graham DY, Yamaoka Y. Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic. Hum Pathol. 2015 Jan; 46(1):129-36. PMID: 25454482.
      Citations: 9     Fields:    Translation:HumansCells
    155. Wang C, Weber A, Graham DY. Age, period, and cohort effects on gastric cancer mortality. Dig Dis Sci. 2015 Feb; 60(2):514-23. PMID: 25274157.
      Citations: 8     Fields:    Translation:HumansCells
    156. Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinjé J, Gregoricus N, Frenck RW, Moe CL, Al-Ibrahim MS, Barrett J, Ferreira J, Estes MK, Graham DY, Goodwin R, Borkowski A, Clemens R, Mendelman PM. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. 2015 Mar 15; 211(6):870-8. PMID: 25210140.
      Citations: 83     Fields:    Translation:HumansCellsPHPublic Health
    157. Trang T, Chan J, Graham DY. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century. World J Gastroenterol. 2014 Sep 07; 20(33):11467-85. PMID: 25206255.
      Citations: 8     Fields:    Translation:HumansAnimals
    158. Shiotani A, Haruma K, Graham DY. Metachronous gastric cancer after successful Helicobacter pylori eradication. World J Gastroenterol. 2014 Sep 07; 20(33):11552-9. PMID: 25206262.
      Citations: 4     Fields:    Translation:HumansCells
    159. Iwatani S, Nagashima H, Reddy R, Shiota S, Graham DY, Yamaoka Y. Identification of the genes that contribute to lactate utilization in Helicobacter pylori. PLoS One. 2014; 9(7):e103506. PMID: 25078575.
      Citations: 4     Fields:    Translation:Cells
    160. Hanada K, Uchida T, Tsukamoto Y, Watada M, Yamaguchi N, Yamamoto K, Shiota S, Moriyama M, Graham DY, Yamaoka Y. Helicobacter pylori infection introduces DNA double-strand breaks in host cells. Infect Immun. 2014 Oct; 82(10):4182-9. PMID: 25069978.
      Citations: 29     Fields:    Translation:HumansCells
    161. Zhang W, Lu H, Graham DY. An Update on Helicobacter pylori as the Cause of Gastric Cancer. Gastrointest Tumors. 2014 Aug; 1(3):155-65. PMID: 26672968.
      Citations:    
    162. Atmar RL, Opekun AR, Estes MK, Graham DY. Reply to Kirby et al. J Infect Dis. 2015 Jan 01; 211(1):167. PMID: 25015947.
      Citations:    Fields:    Translation:HumansCells
    163. Horiuchi A, Graham DY. Special topics in procedural sedation: clinical challenges and psychomotor recovery. Gastrointest Endosc. 2014 Sep; 80(3):404-9. PMID: 24981806.
      Citations: 4     Fields:    Translation:Humans
    164. Yamaoka Y, Graham DY. Helicobacter pylori virulence and cancer pathogenesis. Future Oncol. 2014 Jun; 10(8):1487-500. PMID: 25052757.
      Citations: 50     Fields:    Translation:HumansCells
    165. Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014 May 14; 20(18):5191-204. PMID: 24833849.
      Citations: 43     Fields:    Translation:HumansAnimalsCells
    166. Hanada K, Graham DY. Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma. Expert Rev Anticancer Ther. 2014 Aug; 14(8):947-54. PMID: 24802804.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    167. Nevin DT, Morgan CJ, Graham DY, Genta RM. Helicobacter pylori gastritis in HIV-infected patients: a review. Helicobacter. 2014 Oct; 19(5):323-9. PMID: 24773336.
      Citations: 4     Fields:    Translation:HumansCells
    168. Attumi TA, Graham DY. High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections. Helicobacter. 2014 Aug; 19(4):319-22. PMID: 24698653.
      Citations: 12     Fields:    Translation:HumansCellsCTClinical Trials
    169. Ju H, Brasier AR, Kurosky A, Xu B, Reyes VE, Graham DY. Diagnostics for Statistical Variable Selection Methods for Prediction of Peptic Ulcer Disease in Helicobacter pylori Infection. J Proteomics Bioinform. 2014 Apr 01; 7(4):1000307. PMID: 25132738.
      Citations:    
    170. Wu JY, Wang SS, Lee YC, Yamaoka Y, Graham DY, Jan CM, Wang WM, Wu DC. Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. World J Gastroenterol. 2014 Mar 28; 20(12):3343-9. PMID: 24695835.
      Citations: 3     Fields:    Translation:HumansCells
    171. Wu JY, Hsu PI, Wu DC, Graham DY, Wang WM. Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. Helicobacter. 2014 Jun; 19(3):207-13. PMID: 24612093.
      Citations: 7     Fields:    Translation:HumansCells
    172. Matsueda S, Graham DY. Immunotherapy in gastric cancer. World J Gastroenterol. 2014 Feb 21; 20(7):1657-66. PMID: 24587645.
      Citations:    
    173. Muhsen K, Lagos R, Reymann MK, Graham DY, Pasetti MF, Levine MM. Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR. PLoS One. 2014; 9(1):e83999. PMID: 24454714.
      Citations: 6     Fields:    Translation:HumansCells
    174. Fischbach LA, Graham DY, Kramer JR, Rugge M, Verstovsek G, Parente P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Kolpachi A, Gupta S, Vela MF, Velez M, Cole R, Anand B, El Serag HB. Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol. 2014 Mar; 109(3):357-68. PMID: 24419485.
      Citations: 14     Fields:    Translation:HumansCells
    175. Nijevitch AA, Idrisov B, Akhmadeeva EN, Graham DY. Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance. Curr Pharm Des. 2014; 20(28):4510-6. PMID: 24180406.
      Citations: 3     Fields:    Translation:HumansCells
    176. Trang T, Graham DY. The acid pocket: rediscovery of an old concept. Am J Gastroenterol. 2014 Jan; 109(1):136-7. PMID: 24402539.
      Citations:    Fields:    Translation:Humans
    177. Khandwalla HE, Graham DY, Kramer JR, Ramsey DJ, Duong N, Green LK, El-Serag HB. Barrett's esophagus suspected at endoscopy but no specialized intestinal metaplasia on biopsy, what's next? Am J Gastroenterol. 2014 Feb; 109(2):178-82. PMID: 24343550.
      Citations: 10     Fields:    Translation:Humans
    178. Wu JY, Liou JM, Graham DY. Evidence-based recommendations for successful Helicobacter pylori treatment. Expert Rev Gastroenterol Hepatol. 2014 Jan; 8(1):21-8. PMID: 24410470.
      Citations: 17     Fields:    Translation:HumansCells
    179. Muhsen K, Pasetti MF, Reymann MK, Graham DY, Levine MM. Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. J Infect Dis. 2014 May 01; 209(9):1452-8. PMID: 24273182.
      Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
    180. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, Ramani S, Hill H, Ferreira J, Graham DY. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis. 2014 Apr 01; 209(7):1016-22. PMID: 24253285.
      Citations: 80     Fields:    Translation:HumansCells
    181. Graham DY. Helicobacter pylori eradication and metachronous gastric cancer. Clin Gastroenterol Hepatol. 2014 May; 12(5):801-3. PMID: 24211292.
      Citations: 1     Fields:    Translation:Humans
    182. Dore MP, Cuccu M, Pes GM, Manca A, Graham DY. Lactobacillus reuteri in the treatment of Helicobacter pylori infection. Intern Emerg Med. 2014 Sep; 9(6):649-54. PMID: 24178436.
      Citations: 12     Fields:    Translation:HumansCellsCTClinical Trials
    183. Horiuchi A, Nakayama Y, Kajiyama M, Tanaka N, Sano K, Graham DY. Removal of small colorectal polyps in anticoagulated patients: a prospective randomized comparison of cold snare and conventional polypectomy. Gastrointest Endosc. 2014 Mar; 79(3):417-23. PMID: 24125514.
      Citations: 58     Fields:    Translation:Humans
    184. Lu H, Zhang W, Graham DY. Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China. Eur J Gastroenterol Hepatol. 2013 Oct; 25(10):1134-40. PMID: 23778309.
      Citations: 14     Fields:    Translation:HumansCells
    185. Lina TT, Pinchuk IV, House J, Yamaoka Y, Graham DY, Beswick EJ, Reyes VE. CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection. J Immunol. 2013 Oct 01; 191(7):3838-46. PMID: 23997227.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    186. Trespalacios AA, Otero W, Caminos JE, Mercado MM, Avila J, Rosero LE, Arévalo A, Poutou-Piñales RA, Graham DY. Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia. J Microbiol. 2013 Aug; 51(4):448-52. PMID: 23990295.
      Citations: 2     Fields:    Translation:HumansCells
    187. Shiotani A, Cen P, Graham DY. Eradication of gastric cancer is now both possible and practical. Semin Cancer Biol. 2013 Dec; 23(6 Pt B):492-501. PMID: 23876852.
      Citations:    
    188. Lin D, Kramer JR, Ramsey D, Alsarraj A, Verstovsek G, Rugge M, Parente P, Graham DY, El-Serag HB. Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol. 2013 Oct; 108(10):1576-83. PMID: 23857477.
      Citations: 4     Fields:    Translation:Humans
    189. Sealock RJ, Sabounchi S, Graham DY. Toothpick perforation of the intestines presenting as recurrent abdominal pain: possible roles of abdominal ultrasound and MRI. Clin Med Insights Case Rep. 2013; 6:131-5. PMID: 23885181.
      Citations:    
    190. Fock KM, Graham DY, Malfertheiner P. Helicobacter pylori research: historical insights and future directions. Nat Rev Gastroenterol Hepatol. 2013 08; 10(8):495-500. PMID: 23752823.
      Citations: 29     Fields:    Translation:HumansCells
    191. Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):177-86.e3; Discussion e12-3. PMID: 23751282.
      Citations: 77     Fields:    Translation:HumansCells
    192. Lee YY, Mahendra Raj S, Graham DY. Helicobacter pylori infection--a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter. 2013 Oct; 18(5):338-46. PMID: 23607896.
      Citations: 38     Fields:    Translation:HumansCells
    193. Liao J, Zheng Q, Liang X, Zhang W, Sun Q, Liu W, Xiao S, Graham DY, Lu H. Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy. Helicobacter. 2013 Oct; 18(5):373-7. PMID: 23581720.
      Citations: 20     Fields:    Translation:HumansCells
    194. Shaib YH, Rugge M, Graham DY, Genta RM. Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1374-84. PMID: 23583466.
      Citations: 25     Fields:    Translation:Humans
    195. Maran S, Lee YY, Xu SH, Raj MS, Abdul Majid N, Choo KE, Zilfalil BA, Graham DY. Towards understanding the low prevalence of Helicobacter pylori in Malays: genetic variants among Helicobacter pylori-negative ethnic Malays in the north-eastern region of Peninsular Malaysia and Han Chinese and South Indians. J Dig Dis. 2013 Apr; 14(4):196-202. PMID: 23241512.
      Citations: 7     Fields:    Translation:HumansCells
    196. Shimizu M, Zaninotto G, Nagata K, Graham DY, Lauwers GY. Esophageal squamous cell carcinoma with special reference to its early stage. Best Pract Res Clin Gastroenterol. 2013 Apr; 27(2):171-86. PMID: 23809239.
      Citations:    
    197. Dore MP, Villanacci V, Manca A, Soro S, Schiavo-Lena M, Sabatino G, Graham DY, Bassotti G. Cherry-tree colon: colonoscopic appearance suggesting drug-induced mucosal injury. Intern Emerg Med. 2014 Jun; 9(4):405-9. PMID: 23494541.
      Citations: 1     Fields:    Translation:Humans
    198. El-Serag HB, Hashmi A, Garcia J, Richardson P, Alsarraj A, Fitzgerald S, Vela M, Shaib Y, Abraham NS, Velez M, Cole R, Rodriguez MB, Anand B, Graham DY, Kramer JR. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut. 2014 Feb; 63(2):220-9. PMID: 23408348.
      Citations: 37     Fields:    Translation:Humans
    199. Rimbara E, Sasatsu M, Graham DY. PCR detection of Helicobacter pylori in clinical samples. Methods Mol Biol. 2013; 943:279-87. PMID: 23104297.
      Citations:    
    200. Kramer JR, Fischbach LA, Richardson P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Velez M, Cole R, Anand B, Verstovsek G, Rugge M, Parente P, Graham DY, El-Serag HB. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):373-381.e1. PMID: 23220167.
      Citations: 38     Fields:    Translation:Humans
    201. Graham DY, Gisbert JP. Helicobacter pylori: tailored therapy with novel sequential quadruple therapies. Nat Rev Gastroenterol Hepatol. 2013 Jan; 10(1):6-8. PMID: 23183788.
      Citations: 2     Fields:    Translation:Humans
    202. Nordenstedt H, Graham DY, Kramer JR, Rugge M, Verstovsek G, Fitzgerald S, Alsarraj A, Shaib Y, Velez ME, Abraham N, Anand B, Cole R, El-Serag HB. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013 Jan; 108(1):65-71. PMID: 23147524.
      Citations: 15     Fields:    Translation:HumansCells
    203. Ajami NJ, Barry MA, Carrillo B, Muhaxhiri Z, Neill FH, Prasad BV, Opekun AR, Gilger MA, Graham DY, Atmar RL, Estes MK. Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol. 2012 Dec; 19(12):1980-3. PMID: 23035177.
      Citations: 9     Fields:    Translation:HumansCells
    204. Thirumurthi S, Graham DY. Helicobacter pylori infection in India from a western perspective. Indian J Med Res. 2012 Oct; 136(4):549-62. PMID: 23168695.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    205. Lim YJ, Phan TM, Dial EJ, Graham DY, Lichtenberger LM. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. Digestion. 2012; 86(2):171-7. PMID: 22907267.
      Citations: 7     Fields:    Translation:AnimalsCells
    206. Yagi K, Nakamura A, Sekine A, Graham D. Features of the atrophic corpus mucosa in three cases of autoimmune gastritis revealed by magnifying endoscopy. Case Rep Med. 2012; 2012:368160. PMID: 22811721.
      Citations:    
    207. Cen P, Ni X, Yang J, Graham DY, Li M. Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochim Biophys Acta. 2012 Dec; 1826(2):350-6. PMID: 22683404.
      Citations: 22     Fields:    Translation:HumansCells
    208. Salazar CO, Cardenas VM, Reddy RK, Dominguez DC, Snyder LK, Graham DY. Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics. Helicobacter. 2012 Oct; 17(5):382-90. PMID: 22967122.
      Citations: 12     Fields:    Translation:HumansCells
    209. Dore MP, Fanciulli G, Tomasi PA, Realdi G, Delitala G, Graham DY, Malaty HM. Gastrointestinal symptoms and Helicobacter pylori infection in school-age children residing in Porto Torres, Sardinia, Italy. Helicobacter. 2012 Oct; 17(5):369-73. PMID: 22967120.
      Citations: 9     Fields:    Translation:HumansCells
    210. Graham DY, Shiotani A. Which Therapy for Helicobacter pylori Infection? Gastroenterology. 2012 Jul; 143(1):10-2. PMID: 22613622.
      Citations: 15     Fields:    Translation:HumansCells
    211. Kim YG, Graham DY, Jang BI. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol. 2012 May-Jun; 46(5):397-400. PMID: 22298089.
      Citations: 21     Fields:    Translation:HumansCells
    212. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012 May; 61(5):646-64. PMID: 22491499.
      Citations: 623     Fields:    Translation:HumansCells
    213. Aditi A, Graham DY. Vitamin C, gastritis, and gastric disease: a historical review and update. Dig Dis Sci. 2012 Oct; 57(10):2504-15. PMID: 22543844.
      Citations: 17     Fields:    Translation:HumansCells
    214. Graham DY, Calvet X. Guide regarding choice of second-line therapy to obtain a high cumulative cure rate. Helicobacter. 2012 Aug; 17(4):243-5. PMID: 22759322.
      Citations:    
    215. Tabassam FH, Graham DY, Yamaoka Y. Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cells. Helicobacter. 2012 Jun; 17(3):193-202. PMID: 22515357.
      Citations: 12     Fields:    Translation:HumansCells
    216. Rugge M, Fassan M, Graham DY. Clinical guidelines: Secondary prevention of gastric cancer. Nat Rev Gastroenterol Hepatol. 2012 Feb 14; 9(3):128-9. PMID: 22330815.
      Citations: 5     Fields:    Translation:Humans
    217. Graham DY, Trespalacios AA. Treatment of Helicobacter pylori in Latin America. Lancet. 2012 Feb 04; 379(9814):408; author reply 408-9. PMID: 22305218.
      Citations:    Fields:    Translation:HumansCells
    218. Lee YY, Ismail AW, Mustaffa N, Musa KI, Majid NA, Choo KE, Mahendra Raj S, Derakhshan MH, Malaty HM, Graham DY. Sociocultural and dietary practices among Malay subjects in the north-eastern region of Peninsular Malaysia: a region of low prevalence of Helicobacter pylori infection. Helicobacter. 2012 Feb; 17(1):54-61. PMID: 22221617.
      Citations: 18     Fields:    Translation:HumansCells
    219. Graham DY, Rimbara E. Helicobacter pylori Therapy in the West. Jpn J Helicobacter Res. 2012; 13(2):4-9. PMID: 28133585.
      Citations:    
    220. Li Y, Rimbara E, Thirumurthi S, Trespalacios A, Reddy R, Sabounchi S, Attumi TA, Graham DY. Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days. J Dig Dis. 2012 Jan; 13(1):54-9. PMID: 22188917.
      Citations: 7     Fields:    Translation:HumansCells
    221. Attumi TA, Graham DY. Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study. J Gastroenterol Hepatol. 2012 Jan; 27(1):59-61. PMID: 21793914.
      Citations: 6     Fields:    Translation:HumansCellsCTClinical Trials
    222. Graham DY, Lu H. Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread. Saudi J Gastroenterol. 2012 Jan-Feb; 18(1):1-2. PMID: 22249084.
      Citations: 10     Fields:    Translation:HumansCells
    223. Czakó R, Atmar RL, Opekun AR, Gilger MA, Graham DY, Estes MK. Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol. 2012 Feb; 19(2):284-7. PMID: 22190401.
      Citations: 25     Fields:    Translation:HumansCells
    224. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C, Mendelman PM. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011 Dec 08; 365(23):2178-87. PMID: 22150036.
      Citations: 168     Fields:    Translation:HumansCells
    225. Sugimoto M, Watada M, Jung SW, Graham DY, Yamaoka Y. Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseases. J Clin Microbiol. 2012 Feb; 50(2):441-8. PMID: 22116145.
      Citations: 7     Fields:    Translation:HumansCells
    226. Jang BI, Li Y, Graham DY, Cen P. The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer. Gut Liver. 2011 Dec; 5(4):397-405. PMID: 22195236.
      Citations: 29     Fields:    
    227. Rugge M, Fassan M, Pizzi M, Farinati F, Sturniolo GC, Plebani M, Graham DY. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol. 2011 Nov 07; 17(41):4596-601. PMID: 22147965.
      Citations: 20     Fields:    Translation:Humans
    228. Sugimoto M, Ohno T, Graham DY, Yamaoka Y. Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils. J Gastroenterol Hepatol. 2011 Nov; 26(11):1677-84. PMID: 21679252.
      Citations: 16     Fields:    Translation:AnimalsCells
    229. Graham DY, Jewell NP, Chan FK. Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation. Am J Med Sci. 2011 Nov; 342(5):356-64. PMID: 21986300.
      Citations: 4     Fields:    Translation:Humans
    230. Jung SW, Sugimoto M, Shiota S, Graham DY, Yamaoka Y. The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone. Infect Immun. 2012 Jan; 80(1):381-7. PMID: 22038914.
      Citations: 22     Fields:    Translation:HumansCells
    231. Graham DY, Dore MP. Helicobacter pylori therapy demystified. Helicobacter. 2011 Oct; 16(5):343-5. PMID: 21923679.
      Citations: 8     Fields:    Translation:HumansCells
    232. Dore MP, Farina V, Cuccu M, Mameli L, Massarelli G, Graham DY. Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days. Helicobacter. 2011 Aug; 16(4):295-300. PMID: 21762269.
      Citations: 12     Fields:    Translation:HumansCells
    233. Tabassam FH, Graham DY, Yamaoka Y. Paxillin is a novel cellular target for converging Helicobacter pylori-induced cellular signaling. Am J Physiol Gastrointest Liver Physiol. 2011 Oct; 301(4):G601-11. PMID: 21757638.
      Citations: 7     Fields:    Translation:HumansCells
    234. Reddy R, Penland RL, Osato MS, Graham DY. Maintaining and shipping Helicobacter pylori on agar stabs. Helicobacter. 2011 Jun; 16(3):252-3. PMID: 21585613.
      Citations:    
    235. Kavanagh O, Estes MK, Reeck A, Raju RM, Opekun AR, Gilger MA, Graham DY, Atmar RL. Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol. 2011 Jul; 18(7):1187-90. PMID: 21593238.
      Citations: 13     Fields:    Translation:HumansCells
    236. Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol. 2011 May; 4(3):177-84. PMID: 21694802.
      Citations:    
    237. Graham DY, Rimbara E. Understanding and appreciating sequential therapy for Helicobacter pylori eradication. J Clin Gastroenterol. 2011 Apr; 45(4):309-13. PMID: 21389810.
      Citations: 10     Fields:    Translation:HumansCells
    238. Hsu PI, Wu DC, Wu JY, Graham DY. Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter. 2011 Apr; 16(2):139-45. PMID: 21435092.
      Citations: 60     Fields:    Translation:Humans
    239. Hsu PI, Wu DC, Wu JY, Graham DY. Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days? Helicobacter. 2011 Apr; 16(2):146-52. PMID: 21435093.
      Citations: 27     Fields:    Translation:Humans
    240. Cardenas VM, Prieto-Jimenez CA, Mulla ZD, Rivera JO, Dominguez DC, Graham DY, Ortiz M. Helicobacter pylori eradication and change in markers of iron stores among non-iron-deficient children in El Paso, Texas: an etiologic intervention study. J Pediatr Gastroenterol Nutr. 2011 Mar; 52(3):326-32. PMID: 21336159.
      Citations: 9     Fields:    Translation:HumansCells
    241. Prieto-Jimenez CA, Cardenas VM, Fischbach LA, Mulla ZD, Rivera JO, Dominguez DC, Graham DY, Ortiz M. Double-blind randomized trial of quadruple sequential Helicobacter pylori eradication therapy in asymptomatic infected children in El Paso, Texas. J Pediatr Gastroenterol Nutr. 2011 Mar; 52(3):319-25. PMID: 21336156.
      Citations: 1     Fields:    Translation:HumansCells
    242. Graham DY, Fischbach LA. Empiric therapies for Helicobacter pylori infections. CMAJ. 2011 Jun 14; 183(9):E506-8. PMID: 21343269.
      Citations: 4     Fields:    Translation:HumansCells
    243. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol. 2011 Feb; 8(2):79-88. PMID: 21293508.
      Citations: 61     Fields:    Translation:HumansCells
    244. Ohno T, Vallström A, Rugge M, Ota H, Graham DY, Arnqvist A, Yamaoka Y. Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis. 2011 Mar 01; 203(5):726-35. PMID: 21227917.
      Citations: 21     Fields:    Translation:AnimalsCells
    245. Attumi TA, Graham DY. Follow-up testing after treatment of Helicobacter pylori infections: cautions, caveats, and recommendations. Clin Gastroenterol Hepatol. 2011 May; 9(5):373-5. PMID: 21195791.
      Citations: 9     Fields:    Translation:Humans
    246. El-Serag HB, Graham DY. Routine polypectomy for colorectal polyps and ablation for Barrett's esophagus are intellectually the same. Gastroenterology. 2011 Feb; 140(2):386-8. PMID: 21172329.
      Citations: 5     Fields:    Translation:Humans
    247. Asaka M, Kato M, Graham DY. Strategy for eliminating gastric cancer in Japan. Helicobacter. 2010 Dec; 15(6):486-90. PMID: 21073603.
      Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
    248. Lee YY, Raj SM, Sharif SE, Salleh R, Ayub MC, Graham DY. Incidence of esophageal carcinoma among Malays in North-Eastern Peninsular Malaysia: an area with an exceptionally low prevalence of Helicobacter pylori infection. Dig Dis Sci. 2011 May; 56(5):1438-43. PMID: 21082350.
      Citations: 5     Fields:    Translation:HumansCells
    249. Rahim AA, Lee YY, Majid NA, Choo KE, Raj SM, Derakhshan MH, Graham DY. Helicobacter pylori infection among Aborigines (the Orang Asli) in the northeastern region of Peninsular Malaysia. Am J Trop Med Hyg. 2010 Nov; 83(5):1119-22. PMID: 21036849.
      Citations: 10     Fields:    Translation:HumansCells
    250. Anandasabapathy S, Sontag S, Graham DY, Frist S, Bratton J, Harpaz N, Waye JD. Computer-assisted brush-biopsy analysis for the detection of dysplasia in a high-risk Barrett's esophagus surveillance population. Dig Dis Sci. 2011 Mar; 56(3):761-6. PMID: 20978843.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    251. Reeck A, Kavanagh O, Estes MK, Opekun AR, Gilger MA, Graham DY, Atmar RL. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis. 2010 Oct 15; 202(8):1212-8. PMID: 20815703.
      Citations: 106     Fields:    Translation:HumansCellsCTClinical Trials
    252. Thirumurthi S, Graham DY. Helicobacter pylori infection in India from a western perspective. Indian J Med Sci. 2010 Sep; 64(9):423-40. PMID: 23006422.
      Citations:    Fields:    Translation:HumansCells
    253. Graham DY. Monoclonal stool antigen testing for diagnosing Helicobacter pylori in young children: revisited. J Pediatr Gastroenterol Nutr. 2010 Sep; 51(3):373; author reply 373-4. PMID: 20808180.
      Citations:    
    254. Furuta T, Graham DY. Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection. Gastroenterol Clin North Am. 2010 Sep; 39(3):465-80. PMID: 20951912.
      Citations: 24     Fields:    Translation:HumansCells
    255. Graham DY, Fischbach L. Helicobacter pylori infection. N Engl J Med. 2010 08 05; 363(6):595-6; author reply 596. PMID: 20836243.
      Citations: 6     Fields:    Translation:Humans
    256. Ramirez FC, Osato MS, Graham DY, Woods KL. Addition of gentamicin to endoscopic retrograde cholangiopancreatography (ERCP) contrast medium towards reducing the frequency of septic complications of ERCP. J Dig Dis. 2010 Aug; 11(4):237-43. PMID: 20649737.
      Citations: 4     Fields:    Translation:HumansCells
    257. Graham DY. Helicobacter pylori eradication therapy research: Ethical issues and description of results. Clin Gastroenterol Hepatol. 2010 Dec; 8(12):1032-6. PMID: 20656062.
      Citations: 21     Fields:    Translation:Humans
    258. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010 Aug; 59(8):1143-53. PMID: 20525969.
      Citations: 237     Fields:    Translation:HumansCells
    259. Pang SH, Ching JY, Lau JY, Sung JJ, Graham DY, Chan FK. Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage. Gastrointest Endosc. 2010 Jun; 71(7):1134-40. PMID: 20598244.
      Citations: 34     Fields:    Translation:Humans
    260. Cardenas VM, Mena KD, Ortiz M, Karri S, Variyam E, Behravesh CB, Snowden KF, Flisser A, Bristol JR, Mayberry LF, Ortega YR, Fukuda Y, Campos A, Graham DY. Hyperendemic H. pylori and tapeworm infections in a U.S.-Mexico border population. Public Health Rep. 2010 May-Jun; 125(3):441-7. PMID: 20433039.
      Citations: 8     Fields:    Translation:HumansCells
    261. Yamaoka Y, Reddy R, Graham DY. Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships. J Clin Microbiol. 2010 Jul; 48(7):2550-1. PMID: 20421443.
      Citations: 11     Fields:    Translation:HumansCells
    262. Horiuchi A, Nakayama Y, Kajiyama M, Kato N, Kamijima T, Graham DY, Tanaka N. Biliary stenting in the management of large or multiple common bile duct stones. Gastrointest Endosc. 2010 Jun; 71(7):1200-1203.e2. PMID: 20400079.
      Citations: 23     Fields:    Translation:Humans
    263. Asaka M, Kato M, Graham DY. Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med. 2010; 49(7):633-6. PMID: 20371951.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    264. Leung WK, Graham DY. Obscure gastrointestinal bleeding: where do we go from here? Gastroenterology. 2010 May; 138(5):1655-8. PMID: 20332043.
      Citations: 1     Fields:    Translation:Humans
    265. Graham DY, Javed SU, Keihanian S, Abudayyeh S, Opekun AR. Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States. J Gastroenterol. 2010 Aug; 45(8):816-20. PMID: 20195646.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    266. Shiotani A, Haruma K, Nishi R, Fujita M, Kamada T, Honda K, Kusunoki H, Hata J, Graham DY. Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol. 2010 Mar; 45(3):292-8. PMID: 19968611.
      Citations: 20     Fields:    Translation:Humans
    267. Graham DY, Rugge M. Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol. 2010 Mar; 44(3):167-72. PMID: 20009950.
      Citations: 6     Fields:    Translation:HumansCells
    268. Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, Basso D, Plebani M, Graham DY. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010 May; 31(10):1104-11. PMID: 20180784.
      Citations:    
    269. Sepulveda AR, Yao Y, Yan W, Park DI, Kim JJ, Gooding W, Abudayyeh S, Graham DY. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology. 2010 May; 138(5):1836-44. PMID: 20044995.
      Citations: 36     Fields:    Translation:HumansCells
    270. Pang SH, Graham DY. A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers. Therap Adv Gastroenterol. 2010 Jan; 3(1):11-22. PMID: 21180586.
      Citations:    
    271. Rugge M, de Boni M, Pennelli G, Mescoli C, Graham DY. OLGA can guard the barn. Am J Gastroenterol. 2009 Dec; 104(12):3099; author reply 3101-2. PMID: 19956125.
      Citations:    Fields:    Translation:HumansCells
    272. Dore MP, Graham DY. Ulcers and gastritis. Endoscopy. 2010 Jan; 42(1):38-41. PMID: 19904699.
      Citations:    
    273. Graham DY, Chan FK. Inaccurate endoscopy: a better explanation for placebo-associated endoscopic ulcers. Aliment Pharmacol Ther. 2009 Nov 01; 30(9):955-7; author reply 957-60. PMID: 19807724.
      Citations:    
    274. Wu DC, Hsu PI, Wu JY, Opekun AR, Kuo CH, Wu IC, Wang SS, Chen A, Hung WC, Graham DY. Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol. 2010 Jan; 8(1):36-41.e1. PMID: 19804842.
      Citations: 71     Fields:    Translation:HumansCells
    275. Ogiwara H, Sugimoto M, Ohno T, Vilaichone RK, Mahachai V, Graham DY, Yamaoka Y. Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol. 2009 Nov; 47(11):3493-500. PMID: 19726606.
      Citations: 31     Fields:    Translation:HumansCells
    276. Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010; 45(1):1-8. PMID: 19714291.
      Citations: 28     Fields:    Translation:HumansCellsPHPublic Health
    277. Jung SW, Sugimoto M, Graham DY, Yamaoka Y. homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol. 2009 Oct; 47(10):3241-5. PMID: 19710266.
      Citations: 21     Fields:    Translation:HumansCells
    278. Sugimoto M, Ohno T, Graham DY, Yamaoka Y. Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci. 2009 Nov; 100(11):2152-9. PMID: 19694753.
      Citations: 26     Fields:    Translation:AnimalsCells
    279. Graham DY. Endoscopic ulcers are neither meaningful nor validated as a surrogate for clinically significant upper gastrointestinal harm. Clin Gastroenterol Hepatol. 2009 Nov; 7(11):1147-50. PMID: 19559818.
      Citations: 9     Fields:    Translation:Humans
    280. Vanchiere JA, Abudayyeh S, Copeland CM, Lu LB, Graham DY, Butel JS. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol. 2009 Aug; 47(8):2388-91. PMID: 19494079.
      Citations: 28     Fields:    Translation:HumansCells
    281. Carmack SW, Genta RM, Graham DY, Lauwers GY. Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol. 2009 Jun; 6(6):331-41. PMID: 19421245.
      Citations: 35     Fields:    Translation:Humans
    282. Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis. 2009 May; 10(2):77-84. PMID: 19426388.
      Citations: 32     Fields:    Translation:Cells
    283. Elitsur Y, Tolia V, Gilger MA, Reeves-Garcia J, Schmidt-Sommerfeld E, Opekun AR, El-Zimaity H, Graham DY, Enmei K. Urea breath test in children: the United States prospective, multicenter study. Helicobacter. 2009 Apr; 14(2):134-40. PMID: 19298341.
      Citations: 10     Fields:    Translation:HumansCells
    284. Essa AS, Kramer JR, Graham DY, Treiber G. Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter. 2009 Apr; 14(2):109-18. PMID: 19298338.
      Citations: 68     Fields:    Translation:Humans
    285. Toracchio S, Ota H, de Jong D, Wotherspoon A, Rugge M, Graham DY, Samani A, El-Zimaity HM. Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas. Cancer Sci. 2009 May; 100(5):881-7. PMID: 19320643.
      Citations: 8     Fields:    Translation:HumansCells
    286. Raj SM, Choo KE, Noorizan AM, Lee YY, Graham DY. Evidence against Helicobacter pylori Being Related to Childhood Asthma. J Infect Dis. 2009 Mar 15; 199(6):914-5. PMID: 19239342.
      Citations: 10     Fields:    
    287. Becker MC, Wang TH, Wisniewski L, Wolski K, Libby P, Lüscher TF, Borer JS, Mascette AM, Husni ME, Solomon DH, Graham DY, Yeomans ND, Krum H, Ruschitzka F, Lincoff AM, Nissen SE. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J. 2009 Apr; 157(4):606-12. PMID: 19332185.
      Citations:    
    288. Ohno T, Sugimoto M, Nagashima A, Ogiwara H, Vilaichone RK, Mahachai V, Graham DY, Yamaoka Y. Relationship between Helicobacter pylori hopQ genotype and clinical outcome in Asian and Western populations. J Gastroenterol Hepatol. 2009 Mar; 24(3):462-8. PMID: 19226380.
      Citations: 14     Fields:    Translation:HumansCells
    289. Ramsey PJ, Shaib YH, Graham DY. Appropriate use or overutilization of the CORI database? Am J Gastroenterol. 2009 Mar; 104(3):785-6; author reply 786-7. PMID: 19209169.
      Citations: 2     Fields:    Translation:Humans
    290. Sugimoto M, Graham DY. High-dose versus standard-dose PPI in triple therapy for Helicobacter pylori eradication. Nat Clin Pract Gastroenterol Hepatol. 2009 Mar; 6(3):138-9. PMID: 19174767.
      Citations:    
    291. Moodley Y, Linz B, Yamaoka Y, Windsor HM, Breurec S, Wu JY, Maady A, Bernhöft S, Thiberge JM, Phuanukoonnon S, Jobb G, Siba P, Graham DY, Marshall BJ, Achtman M. The peopling of the Pacific from a bacterial perspective. Science. 2009 Jan 23; 323(5913):527-30. PMID: 19164753.
      Citations: 125     Fields:    Translation:HumansCells
    292. Sugimoto M, Wu JY, Abudayyeh S, Hoffman J, Brahem H, Al-Khatib K, Yamaoka Y, Graham DY. Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples. J Clin Microbiol. 2009 Mar; 47(3):738-42. PMID: 19129407.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    293. Jang JS, Choi SR, Graham DY, Kwon HC, Kim MC, Jeong JS, Won JJ, Han SY, Noh MH, Lee JH, Lee SW, Baek YH, Kim MJ, Jeong DS, Kim SK. Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions. Scand J Gastroenterol. 2009; 44(11):1370-6. PMID: 19891589.
      Citations: 17     Fields:    Translation:Humans
    294. Graham DY. Gastric cancer surveillance or prevention plus targeted surveillance. Jpn J Helicobacter Res. 2009; 10(2):9-14. PMID: 28090424.
      Citations:    
    295. Graham DY, Genta RM. Long-term proton pump inhibitor use and gastrointestinal cancer. Curr Gastroenterol Rep. 2008 Dec; 10(6):543-7. PMID: 19006608.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    296. Graham DY. Efficient identification and evaluation of effective Helicobacter pylori therapies. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):145-8. PMID: 19026766.
      Citations: 36     Fields:    Translation:HumansCells
    297. Schwarz S, Morelli G, Kusecek B, Manica A, Balloux F, Owen RJ, Graham DY, van der Merwe S, Achtman M, Suerbaum S. Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog. 2008 Oct; 4(10):e1000180. PMID: 18949030.
      Citations: 61     Fields:    Translation:HumansCells
    298. Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, Graham DY. Norwalk virus shedding after experimental human infection. Emerg Infect Dis. 2008 Oct; 14(10):1553-7. PMID: 18826818.
      Citations: 186     Fields:    Translation:HumansCells
    299. Abudayyeh S, Hoffman J, El-Zimaity HT, Graham DY. Prospective, randomized, pathologist-blinded study of disposable alligator-jaw biopsy forceps for gastric mucosal biopsy. Dig Liver Dis. 2009 May; 41(5):340-4. PMID: 18799373.
      Citations:    
    300. Tabassam FH, Graham DY, Yamaoka Y. Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol. 2009 Jan; 11(1):70-82. PMID: 18782353.
      Citations: 46     Fields:    Translation:HumansCells
    301. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, Genta RM, Graham DY, Hattori T, Malfertheiner P, Nakajima S, Sipponen P, Sung J, Weinstein W, Vieth M. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008 Aug; 40(8):650-8. PMID: 18424244.
      Citations:    
    302. Dore MP, Graham DY. Gastritis, dyspepsia and peptic ulcer disease. Minerva Med. 2008 Jun; 99(3):323-33. PMID: 18497728.
      Citations:    
    303. Malaty HM, O'Malley KJ, Abudayyeh S, Graham DY, Gilger MA. Multidimensional measure for gastroesophageal reflux disease (MM-GERD) symptoms in children: a population-based study. Acta Paediatr. 2008 Sep; 97(9):1292-7. PMID: 18510718.
      Citations: 3     Fields:    Translation:Humans
    304. Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol. 2008 Jun; 5(6):321-31. PMID: 18446147.
      Citations: 95     Fields:    Translation:HumansCells
    305. Graham DY, Kato M, Asaka M. Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing. Dig Liver Dis. 2008 Jul; 40(7):497-503. PMID: 18403275.
      Citations:    
    306. Cardenas VM, Dominguez DC, Puentes FA, Aragaki CC, Goodman KJ, Graham DY, Fukuda Y. Evaluation of a novel stool native catalase antigen test for Helicobacter pylori infection in asymptomatic North American children. J Pediatr Gastroenterol Nutr. 2008 Apr; 46(4):399-402. PMID: 18367951.
      Citations: 5     Fields:    Translation:HumansCells
    307. Rugge M, Kim JG, Mahachai V, Miehlke S, Pennelli G, Russo VM, Perng CL, Chang FY, Tandon RK, Singal DK, Sung JJ, Valenzuela JE, Realdi G, Dore MP, Graham DY. OLGA gastritis staging in young adults and country-specific gastric cancer risk. Int J Surg Pathol. 2008 Apr; 16(2):150-4. PMID: 18417671.
      Citations: 8     Fields:    Translation:HumansCells
    308. Graham DY, Chan FK. NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology. 2008 Apr; 134(4):1240-6. PMID: 18395101.
      Citations: 13     Fields:    Translation:Humans
    309. Ito K, Yamaoka Y, Ota H, El-Zimaity H, Graham DY. Adherence, internalization, and persistence of Helicobacter pylori in hepatocytes. Dig Dis Sci. 2008 Sep; 53(9):2541-9. PMID: 18320323.
      Citations: 9     Fields:    Translation:HumansCells
    310. Ogiwara H, Graham DY, Yamaoka Y. vacA i-region subtyping. Gastroenterology. 2008 Apr; 134(4):1267; author reply 1268. PMID: 18395110.
      Citations: 28     Fields:    Translation:HumansCells
    311. Ito K, Yamaoka Y, Yoffe B, Graham DY. Disturbance of apoptosis and DNA synthesis by Helicobacter pylori infection of hepatocytes. Dig Dis Sci. 2008 Sep; 53(9):2532-40. PMID: 18253829.
      Citations: 11     Fields:    Translation:HumansCells
    312. Yamauchi K, Choi IJ, Lu H, Ogiwara H, Graham DY, Yamaoka Y. Regulation of IL-18 in Helicobacter pylori infection. J Immunol. 2008 Jan 15; 180(2):1207-16. PMID: 18178861.
      Citations: 17     Fields:    Translation:HumansCells
    313. Toracchio S, El-Zimaity HM, Urmacher C, Katz S, Graham DY. Mycobacterium avium subspecies paratuberculosis and Crohn's disease granulomas. Scand J Gastroenterol. 2008; 43(9):1108-11. PMID: 18609156.
      Citations: 5     Fields:    Translation:HumansCells
    314. Said Essa A, Alaa Eldeen Nouh M, Mohammed Ghaniam N, Graham DY, Said Sabry H. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt. Scand J Infect Dis. 2008; 40(9):730-3. PMID: 19086246.
      Citations: 4     Fields:    Translation:HumansCells
    315. Graham DY, Lu H, Yamaoka Y. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs. 2008; 68(6):725-36. PMID: 18416582.
      Citations: 28     Fields:    Translation:HumansCells
    316. Tabassam FH, Graham DY, Yamaoka Y. OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organization. Cell Microbiol. 2008 Apr; 10(4):1008-20. PMID: 18067607.
      Citations: 29     Fields:    Translation:HumansCells
    317. Pang SH, Leung WK, Graham DY. Ulcers and gastritis. Endoscopy. 2008 Feb; 40(2):136-9. PMID: 18058616.
      Citations:    
    318. Qureshi WA, Wu J, Demarco D, Abudayyeh S, Graham DY. Capsule endoscopy for screening for short-segment Barrett's esophagus. Am J Gastroenterol. 2008 Mar; 103(3):533-7. PMID: 18047544.
      Citations: 1     Fields:    Translation:Humans
    319. Dore MP, Maragkoudakis E, Fraley K, Pedroni A, Tadeu V, Realdi G, Graham DY, Delitala G, Malaty HM. Diet, lifestyle and gender in gastro-esophageal reflux disease. Dig Dis Sci. 2008 Aug; 53(8):2027-32. PMID: 18030622.
      Citations: 27     Fields:    Translation:Humans
    320. Graham DY, Yamaoka Y, Malaty HM. Contemplating the future without Helicobacter pylori and the dire consequences hypothesis. Helicobacter. 2007 Nov; 12 Suppl 2:64-8. PMID: 17991179.
      Citations: 8     Fields:    Translation:HumansCells
    321. Tkachenko MA, Zhannat NZ, Erman LV, Blashenkova EL, Isachenko SV, Isachenko OB, Graham DY, Malaty HM. Dramatic changes in the prevalence of Helicobacter pylori infection during childhood: a 10-year follow-up study in Russia. J Pediatr Gastroenterol Nutr. 2007 Oct; 45(4):428-32. PMID: 18030208.
      Citations: 28     Fields:    Translation:HumansCells
    322. El-Serag HB, Graham DY, Rabeneck L, Avid A, Richardson P, Genta RM. Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers. Scand J Gastroenterol. 2007 Oct; 42(10):1158-66. PMID: 17852849.
      Citations: 3     Fields:    Translation:Humans
    323. Graham DY, Yamaoka Y. Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy. Ann Intern Med. 2007 Sep 18; 147(6):434-5. PMID: 17876031.
      Citations: 3     Fields:    Translation:HumansCells
    324. Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter. 2007 Aug; 12(4):275-8. PMID: 17669098.
      Citations: 91     Fields:    Translation:HumansCells
    325. Graham DY, Yamaoka Y, Malaty HM. Thoughts about populations with unexpected low prevalences of Helicobacter pylori infection. Trans R Soc Trop Med Hyg. 2007 Sep; 101(9):849-51. PMID: 17658569.
      Citations: 10     Fields:    Translation:HumansCells
    326. Graham DY, Yamaoka Y. One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm. Gut. 2007 Jul; 56(7):1021-3; author reply 1022-3. PMID: 17566035.
      Citations: 3     Fields:    Translation:HumansCells
    327. Choi IJ, Fujimoto S, Yamauchi K, Graham DY, Yamaoka Y. Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production. Cell Microbiol. 2007 Oct; 9(10):2457-69. PMID: 17517062.
      Citations: 10     Fields:    Translation:HumansCells
    328. Malaty HM, Abudayyeh S, Fraley K, Graham DY, Gilger MA, Hollier DR. Recurrent abdominal pain in school children: effect of obesity and diet. Acta Paediatr. 2007 Apr; 96(4):572-6. PMID: 17391473.
      Citations: 9     Fields:    Translation:Humans
    329. Lu M, Malladi V, Agha A, Abudayyeh S, Han C, Siepman N, Graham DY. Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. Dig Dis Sci. 2007 Oct; 52(10):2813-20. PMID: 17393309.
      Citations: 3     Fields:    Translation:Humans
    330. Salama NR, Gonzalez-Valencia G, Deatherage B, Aviles-Jimenez F, Atherton JC, Graham DY, Torres J. Genetic analysis of Helicobacter pylori strain populations colonizing the stomach at different times postinfection. J Bacteriol. 2007 May; 189(10):3834-45. PMID: 17337568.
      Citations: 22     Fields:    Translation:HumansCells
    331. Nurgalieva ZZ, Hollinger FB, Graham DY, Zhangabylova S, Zhangabylov A. Epidemiology and transmission of hepatitis B and C viruses in Kazakhstan. World J Gastroenterol. 2007 Feb 28; 13(8):1204-7. PMID: 17451200.
      Citations: 7     Fields:    Translation:Humans
    332. Shiotani A, Opekun AR, Graham DY. Visualization of the small intestine using capsule endoscopy in healthy subjects. Dig Dis Sci. 2007 Apr; 52(4):1019-25. PMID: 17380402.
      Citations: 13     Fields:    Translation:Humans
    333. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, Falush D, Stamer C, Prugnolle F, van der Merwe SW, Yamaoka Y, Graham DY, Perez-Trallero E, Wadstrom T, Suerbaum S, Achtman M. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007 Feb 22; 445(7130):915-918. PMID: 17287725.
      Citations: 323     Fields:    Translation:HumansCells
    334. Graham DY. Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions. Aliment Pharmacol Ther. 2007 Feb 01; 25(3):345-6; author reply 346-7. PMID: 17217449.
      Citations:    
    335. Kudo T, Lu H, Wu JY, Ohno T, Wu MJ, Genta RM, Graham DY, Yamaoka Y. Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbils. Gastroenterology. 2007 Mar; 132(3):1024-38. PMID: 17383425.
      Citations: 17     Fields:    Translation:AnimalsCells
    336. Lu H, Wu JY, Beswick EJ, Ohno T, Odenbreit S, Haas R, Reyes VE, Kita M, Graham DY, Yamaoka Y. Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J Biol Chem. 2007 Mar 02; 282(9):6242-54. PMID: 17202133.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    337. Sipponen P, Graham DY. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol. 2007 Jan; 42(1):2-10. PMID: 17190755.
      Citations: 27     Fields:    Translation:HumansCells
    338. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007 Jun; 56(6):772-81. PMID: 17170018.
      Citations:    
    339. Fujimoto S, Olaniyi Ojo O, Arnqvist A, Wu JY, Odenbreit S, Haas R, Graham DY, Yamaoka Y. Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):49-58. PMID: 17157077.
      Citations: 26     Fields:    Translation:HumansCells
    340. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, Graham DY. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007 May; 56(5):631-6. PMID: 17142647.
      Citations: 97     Fields:    Translation:HumansCells
    341. Shiotani A, Haruma K, Uedo N, Iishi H, Ishihara R, Tatsuta M, Kumamoto M, Nakae Y, Ishiguro S, Graham DY. Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer. Virchows Arch. 2006 Dec; 449(6):652-9. PMID: 17058096.
      Citations:    
    342. Liu Y, Akiyama J, Graham DY. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol. 2006 Sep; 52(3):235-48. PMID: 16971868.
      Citations:    
    343. Graham DY, Abudayyeh S, El-Zimaity HM, Hoffman J, Reddy R, Opekun AR. Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Aliment Pharmacol Ther. 2006 Sep 01; 24(5):845-50. PMID: 16918889.
      Citations:    
    344. Cardenas VM, Ortiz M, Graham DY. Helicobacter pylori eradication and its effect on iron stores: a reappraisal. J Infect Dis. 2006 Sep 01; 194(5):714; author reply 715-6. PMID: 16897673.
      Citations: 1     Fields:    Translation:HumansCells
    345. Graham DY, Shiotani A, El-Zimaity HM. Chromoendoscopy points the way to understanding recovery of gastric function after Helicobacter pylori eradication. Gastrointest Endosc. 2006 Nov; 64(5):686-90. PMID: 17055857.
      Citations: 6     Fields:    Translation:HumansCells
    346. Malaty HM, Abudayyeh S, Graham DY, Gilger MA, Rabeneck L, O'Malley K. A prospective study for the association of Helicobacter pylori infection to a multidimensional measure for recurrent abdominal pain in children. Helicobacter. 2006 Aug; 11(4):250-7. PMID: 16882328.
      Citations: 3     Fields:    Translation:Humans
    347. Opekun AR, Luu P, Gotschall AB, Abdalla N, Torres E, Rudd SB, Graham DY, Nurgalieva ZZ, Tsuchiya K. Point-of-care Helicobacter pylori urine antibody detection in a multi-ethnic adult population in the United States. Transl Res. 2006 Jul; 148(1):13-8. PMID: 16887493.
      Citations: 3     Fields:    Translation:HumansCells
    348. Vilaichone RK, Mahachai V, Graham DY. Helicobacter pylori diagnosis and management. Gastroenterol Clin North Am. 2006 Jun; 35(2):229-47. PMID: 16880064.
      Citations: 14     Fields:    Translation:HumansCells
    349. Graham DY, Uemura N. Natural history of gastric cancer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturally. Helicobacter. 2006 Jun; 11(3):139-43. PMID: 16684259.
      Citations: 13     Fields:    Translation:HumansCells
    350. Wu JY, Lu H, Sun Y, Graham DY, Cheung HS, Yamaoka Y. Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res. 2006 May 15; 66(10):5111-20. PMID: 16707434.
      Citations: 20     Fields:    Translation:HumansCells
    351. Graham DY, Lu H. Is there a role for sequential in sequential anti-H. pylori therapy? Gastroenterology. 2006 May; 130(6):1930-1; author reply 1931. PMID: 16697763.
      Citations: 1     Fields:    Translation:HumansCells
    352. Nurgalieva ZZ, Nugalieva ZZ, Opekun AR, Graham DY. Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections. Helicobacter. 2006 Apr; 11(2):69-74. PMID: 16579835.
      Citations: 7     Fields:    Translation:HumansCells
    353. Graham DY, Nurgalieva ZZ, El-Zimaity HM, Opekun AR, Campos A, Guerrero L, Chavez A, Cardenas V. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol. 2006 Mar; 4(3):306-14. PMID: 16527693.
      Citations: 23     Fields:    Translation:HumansCells
    354. Das S, Suarez G, Beswick EJ, Sierra JC, Graham DY, Reyes VE. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol. 2006 Mar 01; 176(5):3000-9. PMID: 16493058.
      Citations: 60     Fields:    Translation:HumansCells
    355. Cardenas VM, Graham DY, El-Zimaity HM, Opekun AR, Campos A, Chavez A, Guerrero L. Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Aliment Pharmacol Ther. 2006 Jan 15; 23(2):295-301. PMID: 16393310.
      Citations:    
    356. Leung WK, Chan FK, Graham DY. Ulcers and gastritis. Endoscopy. 2006 Jan; 38(1):2-4. PMID: 16429346.
      Citations:    
    357. Abraham NS, Graham DY. NSAIDs and gastrointestinal complications: new clinical challenges. Expert Opin Pharmacother. 2005 Dec; 6(15):2681-9. PMID: 16316306.
      Citations: 3     Fields:    Translation:HumansAnimals
    358. Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006 Jun; 55(6):775-81. PMID: 16322107.
      Citations: 71     Fields:    Translation:HumansCells
    359. Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006 Jan 15; 163(2):127-34. PMID: 16306309.
      Citations: 55     Fields:    Translation:HumansCells
    360. Kudo T, Lu H, Wu JY, Graham DY, Casola A, Yamaoka Y. Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun. 2005 Nov; 73(11):7602-12. PMID: 16239564.
      Citations: 21     Fields:    Translation:HumansCells
    361. Ricuarte O, Gutierrez O, Cardona H, Kim JG, Graham DY, El-Zimaity HM. Atrophic gastritis in young children and adolescents. J Clin Pathol. 2005 Nov; 58(11):1189-93. PMID: 16254110.
      Citations:    
    362. Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol. 2005 Nov; 21(6):653-9. PMID: 16220040.
      Citations: 41     Fields:    Translation:HumansAnimalsCells
    363. Graham DY. Early heartburn relief with proton pump inhibitors and the marketing of zegreid. Clin Gastroenterol Hepatol. 2005 Oct; 3(10):1047; author reply 1047. PMID: 16234053.
      Citations:    Fields:    Translation:Humans
    364. Graham DY. Is real-time testing for helicobacter pylori and corpus atrophy clinically useful in 2005? Endoscopy. 2005 Oct; 37(10):1006-7. PMID: 16189775.
      Citations:    
    365. Opekun AR, Gotschall AB, Abdalla N, Agent C, Torres E, Sutton FM, Graham DY, Tsuchiya K. Improved infrared spectrophotometer for point-of-care patient 13C-urea breath testing in the primary care setting. Clin Biochem. 2005 Aug; 38(8):731-4. PMID: 15963485.
      Citations: 5     Fields:    Translation:HumansCells
    366. Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell. 2005 Oct; 16(10):4954-66. PMID: 16030249.
      Citations: 44     Fields:    Translation:HumansCells
    367. Julapalli VR, Graham DY. Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer. Dig Dis Sci. 2005 Jul; 50(7):1185-93. PMID: 16047458.
      Citations: 7     Fields:    Translation:Humans
    368. Cardenas VM, Graham DY. Smoking and Helicobacter pylori infection in a sample of U.S. adults. Epidemiology. 2005 Jul; 16(4):586-90. PMID: 15951682.
      Citations: 15     Fields:    Translation:HumansCells
    369. Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S, Tatsuta M, Graham DY. Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer. 2005 Jun 20; 115(3):463-9. PMID: 15688378.
      Citations: 25     Fields:    Translation:HumansCells
    370. Opekun AR, Yeh CW, Opekun JL, Graham DY. In vivo tests of natural therapy, Tibetan yogurt or fresh broccoli, for Helicobacter pylori infection. Methods Find Exp Clin Pharmacol. 2005 Jun; 27(5):327-9. PMID: 16082421.
      Citations:    
    371. Graham DY, Shiotani A. The time to eradicate gastric cancer is now. Gut. 2005 Jun; 54(6):735-8. PMID: 15888771.
      Citations:    
    372. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005 Jun; 100(6):1243-50. PMID: 15929752.
      Citations: 137     Fields:    Translation:Humans
    373. Agha A, Opekun AR, Abudayyeh S, Graham DY. Effect of different organic acids (citric, malic and ascorbic) on intragastric urease activity. Aliment Pharmacol Ther. 2005 May 01; 21(9):1145-8. PMID: 15854177.
      Citations:    
    374. Agha A, Graham DY. Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand J Gastroenterol. 2005 May; 40(5):523-9. PMID: 16036504.
      Citations: 23     Fields:    Translation:HumansCells
    375. Nurgalieva ZZ, Conner ME, Opekun AR, Zheng CQ, Elliott SN, Ernst PB, Osato M, Estes MK, Graham DY. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun. 2005 May; 73(5):2999-3006. PMID: 15845507.
      Citations: 13     Fields:    Translation:HumansCells
    376. Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype. Scand J Gastroenterol. 2005 May; 40(5):530-9. PMID: 16036505.
      Citations: 12     Fields:    Translation:HumansCells
    377. Saito H, Yamaoka Y, Ishizone S, Maruta F, Sugiyama A, Graham DY, Yamauchi K, Ota H, Miyagawa S. Roles of virD4 and cagG genes in the cag pathogenicity island of Helicobacter pylori using a Mongolian gerbil model. Gut. 2005 May; 54(5):584-90. PMID: 15831899.
      Citations: 6     Fields:    Translation:AnimalsCells
    378. Shahidzadeh R, Opekun A, Shiotani A, Graham DY. Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Helicobacter. 2005 Apr; 10(2):136-8. PMID: 15810944.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    379. Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology. 2005 Apr; 128(4):833-48. PMID: 15825067.
      Citations: 96     Fields:    Translation:HumansCells
    380. Yamaoka Y, Yamauchi K, Ota H, Sugiyama A, Ishizone S, Graham DY, Maruta F, Murakami M, Katsuyama T. Natural history of gastric mucosal cytokine expression in Helicobacter pylori gastritis in Mongolian gerbils. Infect Immun. 2005 Apr; 73(4):2205-12. PMID: 15784564.
      Citations: 19     Fields:    Translation:AnimalsCells
    381. Graham DY, Chan FK. Endoscopic ulcers with low-dose aspirin and reality testing. Gastroenterology. 2005 Mar; 128(3):807; author reply 807--8. PMID: 15765433.
      Citations: 1     Fields:    Translation:Humans
    382. Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005 Mar; 25(1):197-222. PMID: 15749238.
      Citations: 17     Fields:    Translation:HumansCells
    383. Kudo M, Gutierrez O, El-Zimaity HM, Cardona H, Nurgalieva ZZ, Wu J, Graham DY. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer. J Clin Pathol. 2005 Mar; 58(3):259-62. PMID: 15735156.
      Citations:    
    384. Graham DY, Kudo M, Reddy R, Opekun AR. Practical rapid, minimally invasive, reliable nonendoscopic method to obtain Helicobacter pylori for culture. Helicobacter. 2005 Feb; 10(1):1-3. PMID: 15691309.
      Citations: 9     Fields:    Translation:HumansCells
    385. Wu JY, Kim JJ, Reddy R, Wang WM, Graham DY, Kwon DH. Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother. 2005 Feb; 49(2):578-83. PMID: 15673736.
      Citations: 14     Fields:    Translation:Cells
    386. Malaty HM, Abudayyeh S, O'Malley KJ, Wilsey MJ, Fraley K, Gilger MA, Hollier D, Graham DY, Rabeneck L. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings. Pediatrics. 2005 Feb; 115(2):e210-5. PMID: 15687428.
      Citations: 7     Fields:    Translation:Humans
    387. Nurgalieva ZZ, Wong C, Zhangabylov AK, Omarbekova ZE, Graham DY, Vilchez RA, Butel JS. Polyomavirus SV40 infections in Kazakhstan. J Infect. 2005 Feb; 50(2):142-8. PMID: 15667916.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    388. Graham DY, Opekun AR, Belson G, El-Zimaity HM, Carlson MR. Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori. Aliment Pharmacol Ther. 2005 Jan 15; 21(2):165-8. PMID: 15679766.
      Citations:    
    389. Nurgalieva ZZ, Graham DY, Dahlstrom KR, Wei Q, Sturgis EM. A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. Head Neck. 2005 Jan; 27(1):22-7. PMID: 15459921.
      Citations: 9     Fields:    Translation:HumansCells
    390. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005 Jan; 3(1):55-9. PMID: 15645405.
      Citations: 143     Fields:    Translation:Humans
    391. Graham DY, Chan FK. Is the use of COX-2 inhibitors in gastroenterology cost-effective? Nat Clin Pract Gastroenterol Hepatol. 2004 Dec; 1(2):60-1. PMID: 16265047.
      Citations:    Fields:    Translation:Humans
    392. Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004 Oct; 9(5):453-9. PMID: 15361085.
      Citations: 43     Fields:    Translation:HumansCells
    393. Lu H, Graham DY, Yamaoka Y. The Helicobacter pylori restriction endonuclease-replacing gene, hrgA, and clinical outcome: comparison of East Asia and Western countries. Dig Dis Sci. 2004 Sep; 49(9):1551-5. PMID: 15481336.
      Citations: 7     Fields:    Translation:HumansCells
    394. Graham DY, Opekun AR, Osato MS, El-Zimaity HM, Lee CK, Yamaoka Y, Qureshi WA, Cadoz M, Monath TP. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004 Sep; 53(9):1235-43. PMID: 15306577.
      Citations: 57     Fields:    Translation:HumansCells
    395. Lee KH, Cho MJ, Yamaoka Y, Graham DY, Yun YJ, Woo SY, Lim CY, Ko KS, Kim BJ, Jung HC, Lee WK, Rhee KH, Kook YH. Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells. J Clin Microbiol. 2004 Aug; 42(8):3518-24. PMID: 15297492.
      Citations: 3     Fields:    Translation:AnimalsCells
    396. Nakayama Y, Graham DY. Helicobacter pylori infection: diagnosis and treatment. Expert Rev Anti Infect Ther. 2004 Aug; 2(4):599-610. PMID: 15482223.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    397. El-Serag HB, Petersen NJ, Carter J, Graham DY, Richardson P, Genta RM, Rabeneck L. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004 Jun; 126(7):1692-9. PMID: 15188164.
      Citations: 90     Fields:    Translation:Humans
    398. Graham DY, Belson G, Abudayyeh S, Osato MS, Dore MP, El-Zimaity HM. Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Dig Liver Dis. 2004 Jun; 36(6):384-7. PMID: 15248377.
      Citations:    
    399. Chan FK, Graham DY. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Aliment Pharmacol Ther. 2004 May 15; 19(10):1051-61. PMID: 15142194.
      Citations:    
    400. Kudo T, Nurgalieva ZZ, Conner ME, Crawford S, Odenbreit S, Haas R, Graham DY, Yamaoka Y. Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol. 2004 May; 42(5):2279-81. PMID: 15131212.
      Citations: 30     Fields:    Translation:HumansCells
    401. Yamaoka Y, Kudo T, Lu H, Casola A, Brasier AR, Graham DY. Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology. 2004 Apr; 126(4):1030-43. PMID: 15057743.
      Citations: 59     Fields:    Translation:HumansCells
    402. Ibrahim A, Cole RA, Qureshi WA, Helaly AZ, Jamecci A, Graham DY, Ayub K. Schatzki's ring: to cut or break an unresolved problem. Dig Dis Sci. 2004 Mar; 49(3):379-83. PMID: 15139484.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    403. Graham DY, Opekun AR, Jogi M, Yamaoka Y, Lu H, Reddy R, El-Zimaity HM. False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH. Helicobacter. 2004 Feb; 9(1):17-27. PMID: 15156900.
      Citations: 9     Fields:    Translation:HumansCells
    404. Forman D, Graham DY. Review article: impact of Helicobacter pylori on society-role for a strategy of 'search and eradicate'. Aliment Pharmacol Ther. 2004 Feb; 19 Suppl 1:17-21. PMID: 14725574.
      Citations:    
    405. Nanavati SA, Opekun AR, Hacken-Bitar JB, Cole RA, Anand BS, Graham DY. Migrating shell fragment as a cause of recurrent obscure gastrointestinal bleeding. J Clin Gastroenterol. 2004 Feb; 38(2):137-8. PMID: 14745292.
      Citations:    Fields:    Translation:Humans
    406. Dore MP, Graham DY. Ulcers and gastritis. Endoscopy. 2004 Jan; 36(1):42-7. PMID: 14722854.
      Citations:    
    407. Bochenek WJ, Peters S, Fraga PD, Wang W, Mack ME, Osato MS, El-Zimaity HM, Davis KD, Graham DY. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter. 2003 Dec; 8(6):626-42. PMID: 14632678.
      Citations: 8     Fields:    Translation:HumansCellsCTClinical Trials
    408. Vilaichone RK, Mahachai V, Kositchaiwat C, Graham DY, Yamaoka Y. Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentation. Clin Diagn Lab Immunol. 2003 Nov; 10(6):1025-8. PMID: 14607862.
      Citations: 3     Fields:    Translation:HumansCells
    409. Sakai T, Fukui H, Franceschi F, Penland R, Sepulveda AR, Fujimori T, Terano A, Genta RM, Graham DY, Yamaoka Y. Cyclooxygenase expression during Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci. 2003 Nov; 48(11):2139-46. PMID: 14705819.
      Citations: 9     Fields:    Translation:AnimalsCells
    410. Dore MP, Realdi G, Sepulveda AR, Graham DY. Detection of genomic Helicobacter pylori DNA in the blood of patients positive for the infection. Dig Liver Dis. 2003 Nov; 35(11):839-40. PMID: 14674676.
      Citations:    
    411. Malaty HM, Tanaka E, Kumagai T, Ota H, Kiyosawa K, Graham DY, Katsuyama T. Seroepidemiology of Helicobacter pylori and hepatitis A virus and the mode of transmission of infection: a 9-year cohort study in rural Japan. Clin Infect Dis. 2003 Oct 15; 37(8):1067-72. PMID: 14523771.
      Citations: 4     Fields:    Translation:HumansCells
    412. El-Zimaity HM, Ramchatesingh J, Clarridge JE, Abudayyeh S, Osato MS, Graham DY. Enterococcus gastritis. Hum Pathol. 2003 Sep; 34(9):944-5. PMID: 14562292.
      Citations: 2     Fields:    Translation:HumansCells
    413. Graham DY, Dore MP. The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trials. Gastroenterology. 2003 Aug; 125(2):639; author reply 640-1. PMID: 12891587.
      Citations: 1     Fields:    Translation:HumansCells
    414. Dore MP, Marras L, Maragkoudakis E, Nieddu S, Manca A, Graham DY, Realdi G. Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen. Helicobacter. 2003 Aug; 8(4):307-9. PMID: 12950603.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    415. Kwon DH, Dore MP, Kim JJ, Kato M, Lee M, Wu JY, Graham DY. High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2003 Jul; 47(7):2169-78. PMID: 12821464.
      Citations: 24     Fields:    Translation:HumansCells
    416. Graham DY. The changing epidemiology of GERD: geography and Helicobacter pylori. Am J Gastroenterol. 2003 Jul; 98(7):1462-70. PMID: 12873564.
      Citations: 17     Fields:    Translation:HumansCells
    417. Park CY, Kwak M, Gutierrez O, Graham DY, Yamaoka Y. Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures. J Clin Microbiol. 2003 Jul; 41(7):3336-8. PMID: 12843087.
      Citations: 16     Fields:    Translation:HumansCells
    418. Gutierrez O, Akamatsu T, Cardona H, Graham DY, El-Zimaity HM. Helicobacter pylori and hetertopic gastric mucosa in the upper esophagus (the inlet patch). Am J Gastroenterol. 2003 Jun; 98(6):1266-70. PMID: 12818267.
      Citations: 16     Fields:    Translation:HumansCells
    419. Graham DY, Hammoud F, El-Zimaity HM, Kim JG, Osato MS, El-Serag HB. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2003 May 15; 17(10):1229-36. PMID: 12755836.
      Citations:    
    420. Dore MP, Sepulveda AR, Bacciu PP, Blasi F, Simula L, Marras L, Piccolo D, Cherchi GB, Graham DY, Realdi G. Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Dig Dis Sci. 2003 May; 48(5):945-51. PMID: 12772795.
      Citations: 4     Fields:    Translation:HumansCells
    421. Graham DY, Opekun AR, Hammoud F, Yamaoka Y, Reddy R, Osato MS, El-Zimaity HM. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol. 2003 May; 98(5):1005-9. PMID: 12809820.
      Citations: 32     Fields:    Translation:HumansCells
    422. Graham DY. Changing patterns of peptic ulcer, gastro-oesophageal reflux disease and Helicobacter pylori: a unifying hypothesis. Eur J Gastroenterol Hepatol. 2003 May; 15(5):571-2. PMID: 12702919.
      Citations: 1     Fields:    Translation:HumansCells
    423. Hwang IR, Hsu PI, Peterson LE, Gutierrez O, Kim JG, Graham DY, Yamaoka Y. Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter. 2003 Apr; 8(2):142-8. PMID: 12662382.
      Citations: 13     Fields:    Translation:HumansCells
    424. Graham DY. Helicobacter pylori is not and never was "protective" against anything, including GERD. Dig Dis Sci. 2003 Apr; 48(4):629-30. PMID: 12741448.
      Citations: 8     Fields:    Translation:HumansCells
    425. Willingham FF, Opekun AR, Graham DY. Endoscopic demonstration of transient small bowel intussusception in a patient with adult celiac disease. Gastrointest Endosc. 2003 Apr; 57(4):626-7. PMID: 12665791.
      Citations: 4     Fields:    Translation:Humans
    426. Marchildon PA, Sugiyama T, Fukuda Y, Peacock JS, Asaka M, Shimoyama T, Graham DY, Fukada Y. Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection. J Clin Microbiol. 2003 Apr; 41(4):1480-5. PMID: 12682133.
      Citations: 15     Fields:    Translation:HumansCells
    427. Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, Blaser MJ, Graham DY, Vacher S, Perez-Perez GI, Yamaoka Y, Mégraud F, Otto K, Reichard U, Katzowitsch E, Wang X, Achtman M, Suerbaum S. Traces of human migrations in Helicobacter pylori populations. Science. 2003 Mar 07; 299(5612):1582-5. PMID: 12624269.
      Citations: 337     Fields:    Translation:HumansCells
    428. Sedlácková M, Malaty H, Volf V, Frühauf P, Marx D, Soucek A, Graham DY. [Helicobacter pylori infection in a group of symptomatic and asymptomatic children and adolescents in the Czech Republic]. Cas Lek Cesk. 2003 Feb; 142(2):102-5. PMID: 12698538.
      Citations:    
    429. Graham DY, Opekun AR, Yamaoka Y, Osato MS, el-Zimaity HM. Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther. 2003 Jan; 17(2):193-200. PMID: 12534403.
      Citations: 17     Fields:    Translation:HumansCells
    430. Graham DY. NSAIDs, Helicobacter pylori, and Pandora's Box. N Engl J Med. 2002 Dec 26; 347(26):2162-4. PMID: 12501230.
      Citations: 2     Fields:    Translation:HumansCells
    431. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002 Dec; 123(6):1793-803. PMID: 12454835.
      Citations: 119     Fields:    Translation:HumansCells
    432. Yamaoka Y, Kita M, Kodama T, Imamura S, Ohno T, Sawai N, Ishimaru A, Imanishi J, Graham DY. Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology. 2002 Dec; 123(6):1992-2004. PMID: 12454856.
      Citations: 55     Fields:    Translation:HumansAnimalsCells
    433. Li L, Genta RM, Go MF, Gutierrez O, Kim JG, Graham DY. Helicobacter pylori strain and the pattern of gastritis among first-degree relatives of patients with gastric carcinoma. Helicobacter. 2002 Dec; 7(6):349-55. PMID: 12485121.
      Citations: 8     Fields:    Translation:HumansCells
    434. Park CY, Cho YK, Kodama T, El-Zimaity HM, Osato MS, Graham DY, Yamaoka Y. New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol. 2002 Dec; 40(12):4753-6. PMID: 12454187.
      Citations: 12     Fields:    Translation:HumansCells
    435. Opekun AR, Abdalla N, Sutton FM, Hammoud F, Kuo GM, Torres E, Steinbauer J, Graham DY. Urea breath testing and analysis in the primary care office. J Fam Pract. 2002 Dec; 51(12):1030-2. PMID: 12540328.
      Citations: 2     Fields:    Translation:HumansCells
    436. Shiotani A, Graham DY. Pathogenesis and therapy of gastric and duodenal ulcer disease. Med Clin North Am. 2002 Nov; 86(6):1447-66, viii. PMID: 12510460.
      Citations:    
    437. Li L, Graham DY, Gutierrez O, Kim JG, Genta RM, El-Zimaity HM, Go MF. Genomic fingerprinting and genotyping of Helicobacter pylori strains from patients with duodenal ulcer or gastric cancer from different geographic regions. Dig Dis Sci. 2002 Nov; 47(11):2512-8. PMID: 12452388.
      Citations: 3     Fields:    Translation:HumansCells
    438. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002 Oct 28; 162(19):2197-202. PMID: 12390062.
      Citations: 45     Fields:    Translation:Humans
    439. El-Serag HB, Graham DY, Richardson P, Inadomi JM. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med. 2002 Oct 14; 162(18):2105-10. PMID: 12374519.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    440. Hsu PI, Hwang IR, Cittelly D, Lai KH, El-Zimaity HM, Gutierrez O, Kim JG, Osato MS, Graham DY, Yamaoka Y. Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol. 2002 Sep; 97(9):2231-8. PMID: 12358238.
      Citations: 32     Fields:    Translation:HumansCells
    441. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002 Aug; 123(2):414-24. PMID: 12145793.
      Citations: 133     Fields:    Translation:HumansCells
    442. Nurgalieva ZZ, Malaty HM, Graham DY, Almuchambetova R, Machmudova A, Kapsultanova D, Osato MS, Hollinger FB, Zhangabylov A. Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am J Trop Med Hyg. 2002 Aug; 67(2):201-6. PMID: 12389948.
      Citations: 37     Fields:    Translation:HumansCellsPHPublic Health
    443. Kim JJ, Tao H, Carloni E, Leung WK, Graham DY, Sepulveda AR. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology. 2002 Aug; 123(2):542-53. PMID: 12145807.
      Citations: 47     Fields:    Translation:HumansCells
    444. Graham DY. What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci. 2002 Aug; 47(8):1665-78. PMID: 12184516.
      Citations: 26     Fields:    Translation:Humans
    445. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G, Graham DY, Genta RM. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation. 2002 Jul 23; 106(4):430-4. PMID: 12135941.
      Citations: 30     Fields:    Translation:HumansCells
    446. Dore MP, Malaty HM, Graham DY, Fanciulli G, Delitala G, Realdi G. Risk Factors Associated with Helicobacter pylori Infection among Children in a Defined Geographic Area. Clin Infect Dis. 2002 Aug 01; 35(3):240-5. PMID: 12115088.
      Citations: 15     Fields:    Translation:HumansCells
    447. Malaty HM, Haveman T, Graham DY, Fraley JK. Helicobacter pylori infection in asymptomatic children: impact of epidemiologic factors on accuracy of diagnostic tests. J Pediatr Gastroenterol Nutr. 2002 Jul; 35(1):59-63. PMID: 12142811.
      Citations: 7     Fields:    Translation:HumansCells
    448. Dore MP, Realdi G, Mura D, Graham DY, Sepulveda AR. Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci. 2002 Jul; 47(7):1638-43. PMID: 12141829.
      Citations: 21     Fields:    Translation:HumansCells
    449. Sepulveda A, Peterson LE, Shelton J, Gutierrez O, Graham DY. Histological patterns of gastritis in H. pylori-infected individuals with a family history of gastric cancer. Am J Gastroenterol. 2002 Jun; 97(6):1365-70. PMID: 12094851.
      Citations: 5     Fields:    Translation:HumansCells
    450. Yamaoka Y, Souchek J, Odenbreit S, Haas R, Arnqvist A, Borén T, Kodama T, Osato MS, Gutierrez O, Kim JG, Graham DY. Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol. 2002 Jun; 40(6):2244-6. PMID: 12037098.
      Citations: 42     Fields:    Translation:HumansCells
    451. Qureshi WA, El-Zimaity H, Green LK, Graham DY. Screening for Barrett's esophagus: searching for a new technique. Am J Gastroenterol. 2002 Jun; 97(6):1565-6. PMID: 12094891.
      Citations:    Fields:    Translation:Humans
    452. Graham DY, Malaty HM. Commentary: What remains to be done regarding transmission of Helicobacter pylori. Int J Epidemiol. 2002 Jun; 31(3):646-7. PMID: 12055168.
      Citations:    Fields:    Translation:HumansCells
    453. Sepulveda AR, Graham DY. Role of Helicobacter pylori in gastric carcinogenesis. Gastroenterol Clin North Am. 2002 Jun; 31(2):517-35, x. PMID: 12134616.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    454. Yamaoka Y, Orito E, Mizokami M, Gutierrez O, Saitou N, Kodama T, Osato MS, Kim JG, Ramirez FC, Mahachai V, Graham DY. Helicobacter pylori in North and South America before Columbus. FEBS Lett. 2002 Apr 24; 517(1-3):180-4. PMID: 12062433.
      Citations: 98     Fields:    Translation:HumansCells
    455. Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis. 2002 May 01; 185(9):1335-7. PMID: 12001052.
      Citations: 154     Fields:    Translation:HumansCells
    456. Dore MP, Graham DY, Mele R, Marras L, Nieddu S, Manca A, Realdi G. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Am J Gastroenterol. 2002 Apr; 97(4):857-60. PMID: 12003419.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    457. Leung WK, Graham DY. Rescue Therapy for Helicobacter pylori. Curr Treat Options Gastroenterol. 2002 Apr; 5(2):133-138. PMID: 11879593.
      Citations:    
    458. Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, Yamaoka Y, Berenson GS. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 2002 Mar 16; 359(9310):931-5. PMID: 11918912.
      Citations: 86     Fields:    Translation:HumansCells
    459. El-Zimaity HM, Ota H, Graham DY, Akamatsu T, Katsuyama T. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer. 2002 Mar 01; 94(5):1428-36. PMID: 11920498.
      Citations: 65     Fields:    Translation:Humans
    460. Graham DY. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter. 2002 Feb; 7(1):1-8. PMID: 11886469.
      Citations: 6     Fields:    Translation:HumansCells
    461. Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002 Feb; 16(2):167-80. PMID: 11860399.
      Citations: 233     Fields:    Translation:HumansCells
    462. Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med. 2002 Jan 28; 162(2):169-75. PMID: 11802750.
      Citations: 60     Fields:    Translation:HumansCTClinical Trials
    463. Shiotani A, Yamaoka Y, El-Zimaity HM, Saeed MA, Qureshi WA, Graham DY. NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite. Dig Dis Sci. 2002 Jan; 47(1):38-43. PMID: 11852880.
      Citations: 6     Fields:    Translation:HumansCells
    464. Shiotani A, Saeed A, Yamaoka Y, Osato MS, Klein PD, Graham DY. Citric acid-enhanced Helicobacter pylori urease activity in vivo is unrelated to gastric emptying. Aliment Pharmacol Ther. 2001 Nov; 15(11):1763-7. PMID: 11683690.
      Citations: 4     Fields:    Translation:HumansCells
    465. Shiotani A, Nishioka S, Iguchi M, Yanaoka K, Okada K, Tamai H, Mantani Y, Itoh H, Graham DY. Duodenal erosions after eradication of Helicobacter pylori infection. Gastrointest Endosc. 2001 Oct; 54(4):448-53. PMID: 11577305.
      Citations: 1     Fields:    Translation:HumansCells
    466. Bazzoli F, De Luca L, Graham DY. Helicobacter pylori infection and the use of NSAIDs. Best Pract Res Clin Gastroenterol. 2001 Oct; 15(5):775-85. PMID: 11566040.
      Citations:    Fields:    Translation:HumansCells
    467. El-Zimaity HM, Ramchatesingh J, Saeed MA, Graham DY. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol. 2001 Sep; 54(9):679-83. PMID: 11533073.
      Citations: 32     Fields:    Translation:HumansCells
    468. Kwon DH, Hulten K, Kato M, Kim JJ, Lee M, El-Zaatari FA, Osato MS, Graham DY. DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother. 2001 Sep; 45(9):2609-15. PMID: 11502537.
      Citations: 13     Fields:    Translation:HumansCells
    469. Dore MP, Realdi G, Mura D, Onida A, Massarelli G, Dettori G, Graham DY, Sepulveda AR. Genomic instability in chronic viral hepatitis and hepatocellular carcinoma. Hum Pathol. 2001 Jul; 32(7):698-703. PMID: 11486168.
      Citations: 9     Fields:    Translation:HumansCells
    470. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter. 2001 Jun; 6(2):116-24. PMID: 11422466.
      Citations: 18     Fields:    Translation:HumansCells
    471. Rugge M, Russo V, Busatto G, Genta RM, Di Mario F, Farinati F, Graham DY. The phenotype of gastric mucosa coexisting with Barrett's oesophagus. J Clin Pathol. 2001 Jun; 54(6):456-60. PMID: 11376019.
      Citations: 5     Fields:    Translation:HumansCells
    472. Graham DY, Malaty HM, Cole RA, Martin RF, Klein PD. Simplified 13C-urea breath test for detection of Helicobacter pylori infection. Am J Gastroenterol. 2001 Jun; 96(6):1741-5. PMID: 11419823.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    473. El-Zaatari FA, Osato MS, Graham DY. Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis. Trends Mol Med. 2001 Jun; 7(6):247-52. PMID: 11378513.
      Citations: 27     Fields:    Translation:HumansCells
    474. Yamaoka Y, Graham DY. Clarifications regarding the 3' repeat region of the cagA gene in Helicobacter pylori and clinical outcome. J Clin Microbiol. 2001 Jun; 39(6):2369-70. PMID: 11414245.
      Citations: 3     Fields:    Translation:HumansCells
    475. Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, Graham DY. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med. 2001 May 14; 161(9):1217-20. PMID: 11343444.
      Citations: 40     Fields:    Translation:HumansCells
    476. Hulten K, El-Zimaity HM, Karttunen TJ, Almashhrawi A, Schwartz MR, Graham DY, El-Zaatari FA. Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization. Am J Gastroenterol. 2001 May; 96(5):1529-35. PMID: 11374694.
      Citations: 25     Fields:    Translation:HumansCells
    477. Dore MP, Sepulveda AR, El-Zimaity H, Yamaoka Y, Osato MS, Mototsugu K, Nieddu AM, Realdi G, Graham DY. Isolation of Helicobacter pylori from sheep-implications for transmission to humans. Am J Gastroenterol. 2001 May; 96(5):1396-401. PMID: 11374673.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    478. El-Zimaity HM, Graham DY. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol. 2001 May; 96(5):1378-82. PMID: 11374671.
      Citations: 11     Fields:    Translation:Humans
    479. Malaty HM, Logan ND, Graham DY, Ramchatesingh JE. Helicobacter pylori infection in preschool and school-aged minority children: effect of socioeconomic indicators and breast-feeding practices. Clin Infect Dis. 2001 May 15; 32(10):1387-92. PMID: 11317237.
      Citations: 16     Fields:    Translation:HumansCells
    480. Kim JJ, Reddy R, Lee M, Kim JG, El-Zaatari FA, Osato MS, Graham DY, Kwon DH. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001 Apr; 47(4):459-61. PMID: 11266421.
      Citations: 46     Fields:    Translation:HumansCells
    481. Graham DY, Saeed MA, Hoffman J, El-Zimaity HM, Kwon DH, Osato MS. Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. Aliment Pharmacol Ther. 2001 Apr; 15(4):513-8. PMID: 11284780.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    482. Griffiths RI, Rabeneck L, Guzman G, Cromwell DM, Strauss MJ, Robinson JW, Winston B, Li T, Graham DY. Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy. Helicobacter. 2001 Mar; 6(1):66-76. PMID: 11328368.
      Citations:    Fields:    Translation:HumansCells
    483. Gutierrez O, Kim JG, Akamatsu T, Gürer IE, Simjee AE, Graham DY. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol. 2001 Mar; 96(3):666-72. PMID: 11280531.
      Citations: 10     Fields:    Translation:HumansCells
    484. Chamberlin W, Graham DY, Hulten K, El-Zimaity HM, Schwartz MR, Naser S, Shafran I, El-Zaatari FA. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol Ther. 2001 Mar; 15(3):337-46. PMID: 11207508.
      Citations: 41     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    485. El-Zimaity HM, Graham DY. Ultrastructural evidence of in vivo phagocytosis of Helicobacter pylori. Ultrastruct Pathol. 2001 Mar-Apr; 25(2):159. PMID: 11407530.
      Citations: 2     Fields:    Translation:HumansCells
    486. Dore MP, Kwon DH, Sepulveda AR, Graham DY, Realdi G. Stable amoxicillin resistance in Helicobacter pylori. Helicobacter. 2001 Mar; 6(1):79. PMID: 11328370.
      Citations: 1     Fields:    Translation:HumansCells
    487. Graham DY, Malaty HM. Alendronate and naproxen are synergistic for development of gastric ulcers. Arch Intern Med. 2001 Jan 08; 161(1):107-10. PMID: 11146706.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    488. Graham DY. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Am J Med. 2001 Jan 08; 110(1A):58S-61S. PMID: 11166000.
      Citations: 2     Fields:    Translation:HumansCells
    489. Leung WK, Graham DY. Ulcer and gastritis. Endoscopy. 2001 Jan; 33(1):8-15. PMID: 11204993.
      Citations: 1     Fields:    Translation:HumansCells
    490. Kwon DH, Lee M, Kim JJ, Kim JG, El-Zaatari FA, Osato MS, Graham DY. Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob Agents Chemother. 2001 Jan; 45(1):306-8. PMID: 11120984.
      Citations: 16     Fields:    Translation:HumansCells
    491. Hulten K, Karttunen TJ, El-Zimaity HM, Naser SA, Almashhrawi A, Graham DY, El-Zaatari FA. In situ hybridization method for studies of cell wall deficient M. paratuberculosis in tissue samples. Vet Microbiol. 2000 Dec 20; 77(3-4):513-8. PMID: 11118736.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    492. Naser SA, Hulten K, Shafran I, Graham DY, El-Zaatari FA. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Vet Microbiol. 2000 Dec 20; 77(3-4):497-504. PMID: 11118734.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    493. Graham DY, Klein PD. Accurate diagnosis of Helicobacter pylori. 13C-urea breath test. Gastroenterol Clin North Am. 2000 Dec; 29(4):885-93, x. PMID: 11190073.
      Citations: 14     Fields:    Translation:HumansCells
    494. Lanza F, Schwartz H, Sahba B, Malaty HM, Musliner T, Reyes R, Quan H, Graham DY. An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae. Am J Gastroenterol. 2000 Nov; 95(11):3112-7. PMID: 11095326.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    495. Kwon DH, Kim JJ, Lee M, Yamaoka Y, Kato M, Osato MS, El-Zaatari FA, Graham DY. Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother. 2000 Nov; 44(11):3203-5. PMID: 11036054.
      Citations: 18     Fields:    Translation:HumansCells
    496. Hulten K, Karttunen TJ, El-Zimaity HM, Naser SA, Collins MT, Graham DY, El-Zaatari FA. Identification of cell wall deficient forms of M. avium subsp. paratuberculosis in paraffin embedded tissues from animals with Johne's disease by in situ hybridization. J Microbiol Methods. 2000 Oct; 42(2):185-95. PMID: 11018275.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    497. Graham DY, Qureshi WA. Antibiotic-resistant H. pylori infection and its treatment. Curr Pharm Des. 2000 Oct; 6(15):1537-44. PMID: 10974150.
      Citations: 17     Fields:    Translation:HumansCells
    498. Nakajima S, Graham DY, Hattori T, Bamba T. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000. Curr Pharm Des. 2000 Oct; 6(15):1503-14. PMID: 10974147.
      Citations: 2     Fields:    Translation:HumansCells
    499. Opekun AR, Gilger MA, Denyes SM, Nirken MH, Philip SP, Osato MS, Malaty HM, Hicks J, Graham DY. Helicobacter pylori infection in children of Texas. J Pediatr Gastroenterol Nutr. 2000 Oct; 31(4):405-10. PMID: 11045838.
      Citations: 12     Fields:    Translation:HumansCells
    500. Shiotani A, Nurgalieva ZZ, Yamaoka Y, Graham DY. Helicobacter pylori. Med Clin North Am. 2000 Sep; 84(5):1125-36, viii. PMID: 11026921.
      Citations: 5     Fields:    Translation:HumansCells
    501. Dore MP, Osato MS, Malaty HM, Graham DY. Characterization of a culture method to recover Helicobacter pylori from the feces of infected patients. Helicobacter. 2000 Sep; 5(3):165-8. PMID: 10971682.
      Citations: 8     Fields:    Translation:HumansCells
    502. Malaty HM, Logan ND, Graham DY, Ramchatesingh JE, Reddy SG. Helicobacter pylori infection in asymptomatic children: comparison of diagnostic tests. Helicobacter. 2000 Sep; 5(3):155-9. PMID: 10971680.
      Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
    503. el-Zimaity HM, Verghese VJ, Ramchatesingh J, Graham DY. The gastric cardia in gastro-oesophageal disease. J Clin Pathol. 2000 Aug; 53(8):619-25. PMID: 11002767.
      Citations: 8     Fields:    Translation:HumansCells
    504. Kwon DH, El-Zaatari FA, Kato M, Osato MS, Reddy R, Yamaoka Y, Graham DY. Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother. 2000 Aug; 44(8):2133-42. PMID: 10898687.
      Citations: 38     Fields:    Translation:HumansCells
    505. Kato M, Yamaoka Y, Kim JJ, Reddy R, Asaka M, Kashima K, Osato MS, El-Zaatari FA, Graham DY, Kwon DH. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother. 2000 Aug; 44(8):2214-6. PMID: 10898707.
      Citations: 22     Fields:    Translation:HumansCells
    506. Kwon DH, Kato M, El-Zaatari FA, Osato MS, Graham DY. Frame-shift mutations in NAD(P)H flavin oxidoreductase encoding gene (frxA) from metronidazole resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance. FEMS Microbiol Lett. 2000 Jul 15; 188(2):197-202. PMID: 10913705.
      Citations: 14     Fields:    Translation:HumansCells
    507. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A. 2000 Jun 20; 97(13):7533-8. PMID: 10852959.
      Citations: 162     Fields:    Translation:HumansCells
    508. Yamaoka Y, Malaty HM, Osato MS, Graham DY. Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis. 2000 Jun; 181(6):2083-6. PMID: 10837199.
      Citations: 15     Fields:    Translation:HumansCells
    509. Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000 Jun; 95(6):1431-8. PMID: 10894575.
      Citations: 57     Fields:    Translation:HumansCells
    510. Kwon DH, Osato MS, Graham DY, El-Zaatari FA. Quantitative RT-PCR analysis of multiple genes encoding putative metronidazole nitroreductases from Helicobacter pylori. Int J Antimicrob Agents. 2000 Jun; 15(1):31-6. PMID: 10856674.
      Citations: 3     Fields:    Translation:Cells
    511. Graham DY, Osato MS, Hoffman J, Opekun AR, Anderson SY, Kwon DH, El-Zimaity HM. Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study. Aliment Pharmacol Ther. 2000 Jun; 14(6):745-50. PMID: 10848658.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    512. Dore MP, Bilotta M, Malaty HM, Pacifico A, Maioli M, Graham DY, Realdi G. Diabetes mellitus and Helicobacter pylori infection. Nutrition. 2000 Jun; 16(6):407-10. PMID: 10869894.
      Citations: 23     Fields:    Translation:HumansCells
    513. Estes MK, Ball JM, Guerrero RA, Opekun AR, Gilger MA, Pacheco SS, Graham DY. Norwalk virus vaccines: challenges and progress. J Infect Dis. 2000 May; 181 Suppl 2:S367-73. PMID: 10804150.
      Citations: 17     Fields:    Translation:HumansCells
    514. Malaty HM, Kumagai T, Tanaka E, Ota H, Kiyosawa K, Graham DY, Katsuyama T. Evidence from a nine-year birth cohort study in Japan of transmission pathways of Helicobacter pylori infection. J Clin Microbiol. 2000 May; 38(5):1971-3. PMID: 10790131.
      Citations: 11     Fields:    Translation:HumansCells
    515. Sepulveda AR, Wu L, Ota H, Gutierrez O, Kim JG, Genta RM, Graham DY. Molecular identification of main cellular lineages as a tool for the classification of gastric cancer. Hum Pathol. 2000 May; 31(5):566-74. PMID: 10836295.
      Citations: 6     Fields:    Translation:HumansCells
    516. El-Zimaity HM, Graham DY, Genta RM, Lechago J. Sustained increase in gastric antral epithelial cell proliferation despite cure of Helicobacter pylori infection. Am J Gastroenterol. 2000 Apr; 95(4):930-5. PMID: 10763940.
      Citations: 4